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Abstract
Stem cells are powerful tools in different aspects of biomedical and
translational research, including disease modeling, drug testing, and tissue engineering
for regenerative medicine. However, isolation and culture of organ-specific stem cells
are challenging tasks. Therefore, the biological features of many adult stem cells are
not well studied and their involvement in the development of cancer is still
controversial. Some immortal stem cell lines have been established and used as an
alternative to study features of organ-specific stem cells. The ability to grow cells in a
scaffold-free, three-dimensional (3D) model system that mimics in vivo conditions
would help in revealing more and more properties of stem cells.
In this study, two types of 3D culture models were established to define specific
properties of gastric stem cells. In the first model, the hanging drop method was used
to grow an immortalized mouse gastric epithelial progenitor/stem (mGS) cells with
molecular and morphological features similar to those of stomach stem cells. Within a
day, mGS cells hanging in RPMI media containing 10% serum without adding any
growth factors formed a small cluster. By day 2, when transferred onto the surface of
agarose using same media, each cell cluster developed into a small spherical organoid
with a central lumen, characterized by electron microscopy. Due to cell proliferation,
these organoids progressively grew in size and were maintained for six months. The
second type of organoids was developed from incipient gastric glands freshly isolated
from neonatal mouse stomach using the matrigel method. Organoids were developed
within a day and were maintained for up to 10 days. The stem cell contribution and
cellular dynamics during formation of these organoids were investigated using
bromodeoxyuridine labeling. Organoids were further characterized at different time
points by using calcein-propidium iodide labeling, electron microscopy, lectin
histochemistry,

immunohistochemistry

and

quantitative

reverse-transcription

polymerase chain reactions. Evidences of differentiation into gastric mucus-producing
epithelial cells were detected.
To use the gastric organoids as a model for investigating the role of arylhydrocarbon receptors (AhR), one of the important factors involved in stem cell
control as well as in the pathogenesis of cancer. Their expression levels were first
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tested using immunohistochemistry. Data revealed the localization of AhR in mGS
cells and cells forming the gastric primary organoids. These findings correlated with
the cellular expression of AhR in gastric mucosa of mice, rats and humans.
Immunolabeled cells were located in the middle of gastric glands where dividing stem
cells are located. To test the consequences of AhR activation, two-day-old organoids
were incubated with 0.1 and 1.0 nM of dioxin for two days. Upregulation of
cytochrome P450 indicated activation of AhR. This was associated with upregulation
of Oct-4 expression which suggested enhancement of self-renewal of gastric stem
cells. Similar findings were observed in human gastric precancerous and cancer
tissues.
In conclusion, gastric organoids are useful models to study regulation of gastric
stem cells. Activation of AhR plays an important role in gastric stem cell self-renewal
via Oct-4 upregulation. This could also explain a role for AhR in gastric cancer
development. This study provides new insights into gastric stem cells which help in
better understanding of their roles in tissue engineering and gastric cancer.

Keywords: Stem cells, Cell proliferation, Cell differentiation, Stomach, 3D culture,
Organoids, Aryl-hydrocarbon receptors.
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)Title and Abstract (in Arabic

إنشاء عضيات من الخاليا الجذعية المعدية واستخدامها لدراسة دور مستقبالت أريل
الهيدروكربونية
الملخص

تعتبر الخاليا الجذعية أدوات قوية في جوانب مختلفة من البحوث الطبية الحيوية
والتطبيقية ،بما في ذلك نمذجة المرض ،واختبار األدوية ،وهندسة األنسجة للطب التجديدي .ومع
ذلك ،فإن فصل وزراعة الخاليا الجذعية الخاصة باألعضاء هي مهمة صعبة .لذلك ،لم يتم دراسة
السمات البيولوجية للعديد من الخاليا الجذعية البالغة بشكل جيد وال يزال دورها في تطور
السرطان مثير للجدل .تم إنشاء بعض خطوط الخاليا الجذعية الخالدة في معملنا وتم أيضا
استخدامها كبديل لدراسة صفات الخاليا الجذعية الخاصة باألعضاء .إن القدرة على نمو الخاليا
في نظام نموذج ثالثي األبعاد  3Dالذي يشابه ظروف الجسم الحي من شأنها أن تساعد في الكشف
عن المزيد والمزيد من خصائص الخاليا الجذعية.
في هذه الدراسة ،تم إنشاء نوعين من نماذج ثالثية األبعاد لدراسة خصائص الخاليا
الجذعية المعدية .في النموذج األول ،تم استخدام طريقة القطرة المعلقة لنمو الخاليا الجذعية
المخلدة المشابهة لتلك الموجودة في الخاليا الجذعية في معدة الفئران .في غضون يوم ،شكلت
الخاليا كتلة مستديرة صغيرة في وجود  RPMIالتي تحتوي على  ٪10من مصل الدم دون إضافة
أي عوامل نمو أخرى .بعد نقلها إلى سطح مادة األجاروز ،تطورت كل كتلة من الخاليا إلى شكل
كروي ينمو يوما بعد يوم بسبب تكاثر الخاليا و يمكن الحفاظ عليها لعدة أشهر و تم فحص هذه
العضيات بالمجهر اإللكتروني .أما النوع الثاني من العضيات فقد تم إنشاءها من غدد المعدة األولية
ً
حديث الوالدة باستخدام مادة الماتريجل .تم تكوين العضيات في غضون
المفصولة من معدة الفأر
يوم واحد وإستمر نموها لمدة تصل إلى  10أيام .تم تحديد مساهمة الخاليا الجذعية و ديناميكياتها
أثناء تكوين هذه العضيات باستخدام طرق معملية عديدة ،و تم الكشف عن أدلة لتمايز هذه الخاليا
لتصبح منتجة لمخاط المعدة.
الستخدام نموذج عضيات المعدة لدراسة دور مستقبالت أريل الهيدروكربونية )،(AhR
وهى أحد العوامل الهامة التي تسيطر على الخاليا الجذعية وكذلك تشارك في التسبب في سرطان
المعدة تم اختبار مستويات التعبير عنها أوالً باستخدام الكيمياء المناعية على األنسجة .كشفت
ضا
النتائج أن بعض خاليا أعضاء المعدة تحتوى على  ،AhRو تم تأكيد هذه النتائج أي ً

x

بواسطة  qRT-PCRفي أنسجة المعدة لدى الفئران والجرذان واإلنسان .توجد هذه الخاليا التي
تحتوى على  AhRفي منتصف الغدد المعدية حيث توجد الخاليا الجذعية وأظهرت التعبير
السيتوبالزمي والنووي .لتنشيط  ،AhRتمت معالجة عضيات بعمر يومين مع  0.1و 1.0
نانومولر من الديوكسين لمدة يومين .كشفت النتائج عن زيادة تنظيم السيتوكروم  P450الذي يؤكد
ضا زيادة في  Oct-4الذي يعزز التجديد الذاتي للخاليا الجذعية
نجاح تنشيط  .AhRكان هناك أي ً
المعدية .تم دعم وتطبيق هذه النتائج من خالل دراسة كل من  AhRو  Oct-4في أنسجة السرطان
في المعدة.
في الختام ،هذه الدراسة ساعدت على إنشاء عضيات المعدة وتم استخدامها لدراسة
الصفات البيولوجية للخاليا الجذعية في المعدة و للتعرف على دور  AhRفي التجديد الذاتي
للخاليا الجذعية وبالتالي يمكن استخدامها في المستقبل في هندسة و زراعة أنسجة المعدة و يمكن
تطبيقها على أبحاث لهدف تشخيصي و/أو عالجي لمرضى سرطان المعدة.
مفاهيم البحث الرئيسية :الخاليا الجذعية ،تكاثر الخاليا ،تمايز الخاليا ،المعدة ،زراعة الخاليا
ثالثية األبعاد ،مستقبالت أريل الهيدروكربونية.
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Chapter 1: Introduction
1.1 Overview
Stem cells are undifferentiated cells with unique capacity to self-renew and
differentiate into specialized cell types in the body. There are two main types of stem
cell, embryonic stem cells and adult stem cells. Embryonic stem cells are known as
pluripotent stem cells as they can give rise to any type of somatic cells in the body.
Adult stem cells are found in adult tissues and usually used to repair and replace any
damaged cells in the tissues. Stem cell research is one of the most fascinating areas in
biomedical field because of their potential to proliferate and regenerate to produce
different adult cell types. Current therapies, such as regenerative medicine, are already
making use of the regenerative property stem cells. Apart from regenerating or
repairing, stem cells are also believed to be involved in cancer development. However,
this hypothesis is still under debate due to difficulties in stem cell research. One of the
major difficulties is isolating and culturing the cells in vitro. Therefore, it is always
preferable to use other representative models such as immortal cell lines or 3D cell
cultures which will help better understand the functional characteristic features of the
stem cells.
1.2 Statement of the problem
Gastric cancer is the second most fatal cancer worldwide (Ang & Fock, 2014).
Though many genetic and environmental factors are associated with the gastric cancer,
the detailed mechanism of its development is still unclear. Some studies suggested that
the adult epithelial cells are the ones that are transdifferentiated back to its proliferative
state to become cancer stem cells and develop gastric cancer (Han & Oh, 2013).
However, recent studies suggested that adult stem cells transform into cancer stem
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cells and proliferate to develop cancer (Vaidya, Bacchus, & Sugaya, 2018; Zhu et al.,
2009). Stem cells in the stomach may also cause cancer due to chronic inflammation
resulting in genetic and epigenetic alterations in the stem cell niche (Hayakawa, Fox,
& Wang, 2017). However, due to lack of sufficient understanding of molecular control
of gastric stem cells, their involvement in gastric cancer is still remaining
controversial. Some of the stem cell regulatory proteins may also have major effects
on the gastric cancer progression. Therefore, mimicking in vivo conditions in the 3D
organoid models might help to dissect the functional features of stem cells and their
mechanistic role during cancer progression. These 3D models are better than the usual
2D culture where cells lose their physiological characteristics and do not mimic the in
vivo condition.
1.3 Relevant literature
Stomach, a muscular organ which is located on the left side of the upper
abdomen and receives food from the esophagus through lower esophageal sphincter.
It secretes acid and enzymes used to digest food. The stomach muscles contract
occasionally, churning food to improve digestion. The pyloric sphincter is a muscular
valve that opens to allow the food from the stomach to move towards the small
intestine.
1.3.1 Anatomy and histology of the stomach
The stomach is the main food processing organ of the digestive tract, which
secretes a mixture of acid, mucus, and enzymes required for digestion. It is also the
source of various hormones that control cell functions. It is a hollow, J-shaped organ
located in the upper abdomen connecting the esophagus with the intestine.
Anatomically, the stomach includes four regions: cardia, fundus, corpus and the
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pyloric region. The stomach wall is made up of four layers. The outermost is the
visceral peritoneal layer or the serosa, which is followed by the muscularis layer made
of smooth muscle fibers, the submucosal connective tissue layer, and the innermost
mucosal layer.
The gastric mucosa in humans and mice is very similar and divided into 4 parts
fundus, cardia, corpus and pylorus. While in humans, the cardia is continuous with the
esophagus, in mice, the fundus is continuous with the esophagus and the cardia forms
a thin small area between the forestomach and the corpus. The gastric mucosa includes
the lining cells that are organized in a monolayer of simple columnar epithelium with
deep invaginations forming millions of tubular glands (Figure 1) (Bjerknes & Cheng,
2002; Karam & Leblond, 1993). The corpus glands are divided into four parts: pit,
isthmus, neck, and base. The types of cells present in the glands in the corpus region
are pepsinogen-secreting zymogenic cells, mucus-secreting cells which helps to
protect the lining epithelium, acid secreting parietal cells which in human also produce
intrinsic factor, hormone-secreting endocrine cells, and mucous neck cells. The
percentage of these cells estimated in tissue sections were represented as 35%, 19%,
13%, 7%, and 6%, respectively (Karam & Leblond, 1992). The glands in the cardiac
and pyloric regions are smaller than those of the corpus and composed mostly of two
types of mucous cells and endocrine cells.
1.3.1.1 Gastric stem cells
Unlike the differentiated body cells, stem cells are undifferentiated with the
ability to proliferate to self-renew and to differentiate in specialized cell types.
Basically, there are two major kinds of stem cells: embryonic stem cells that can give
rise to any cell types; adult stem cells which are normally present in body tissues, helps
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organs in replacing damaged and dead cells due to some injury or usual cell renewal
process.
All the gastric epithelial cells mentioned above originate from the gastric stem
cells which divide to maintain themselves and replace the old degenerating cells. These
stem cells are present in the isthmus region of the gastric gland and were detected in
mice using 3H-thymidine radiography and electron microscopy techniques. 3Hthymidine radiography was used to label and detect the dividing cells and electron
microscopy was used to characterize the ultrastructural features of the undifferentiated cells (Karam & Leblond, 1993). While the stem cells differentiate, they
migrate in two directions: 1) toward the luminal surface to become surface mucous
cells, and 2) towards the bottom of the gland to become mucous neck cells and then
zymogenic cells. Both endocrine and parietal cells complete their differentiation in the
isthmus region and then migrate not only toward the gland bottom, but also a few
migrate toward the luminal surface. This epithelial turnover is necessary to maintain
healthy epithelial glands and to replace the dead or damaged cells due to harsh acidic
environment in the stomach. The gastric stem cells are also called granule-free cells.
They are the most proliferating cells and give rise to pre-parietal cells, pre-pit cells,
pre-neck cells, pre-endocrine cells and pre-tuft cells. The granule-free cells can be
found anywhere in the isthmus region, while pre-pit cells are located near the isthmuspit edge and pre-neck cells at the isthmus-neck edge. The gastric stem cells are
undifferentiated cells with no secretory granules, but there are few small granules in
pre-pit and pre-neck cells (progenitor cells). Electron microscopic studies of these
stem/progenitor cells have demonstrated that they have larger nucleoli (2.0-2.5 µm²)
with higher nucleus to cytoplasm ratio and smaller mitochondrial diameter (300-375
nm) than the mature cells. Moreover, the stem cells are of three subtypes, two of these
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subtypes contain few small prosecretory granules near to the trans-face of the Golgi
apparatus. This is an indication to the secretory activity of the Golgi apparatus to form
secretory granules. In pre-pit and pre-neck cells, the content in the prosecretory
vesicles are similar to the pit and neck cells respectively but with difference in the
stages of condensation of secretory granules. The stem cells are characterized by the
presence of immature Golgi, no prosecretory vesicles, therefore they are not involved
in any secretion process (Karam & Leblond, 1993). Moreover, these cells also have
characteristic features similar to primitive undifferentiated embryonic cells that are: 1)
large nucleus containing reticulated nucleoli with diffuse chromatin and 2) the
cytoplasm contains many free ribosomes along with very few numbers of small
mitochondria and rough endoplasmic reticulum (Mizuno & Ishizuya, 1982). These
undifferentiated and highly proliferative stem cells further differentiate and mature
towards parietal cells, pit cells, neck cells, endocrine cells and tuft cells in the gland
(Karam, 1993; Karam & Leblond, 1993) (Figure 2).
In addition, lineage tracing experiments done to study gastric stem cell
dynamics helped in identification of other stem cells other than the stem cells present
in the isthmus region. These experiments were also helpful to find various molecular
markers expressed in those progenitor cells. The first proliferating cell marker
identified was villin, an actin-binding protein, expressed in specific type of epithelial
cells, rarely found in the pyloric region. It was discovered from transgenic mice that
express Villin promoter-driven LacZ or GFP reporter. These long-lived cells known
as Villin promoter-marked gastric stem cells (V-GSCs) are inactive in proliferation
and have the capability to differentiate to multiple cell types (Braunstein et al., 2002;
Qiao et al., 2007)
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Another highly-proliferative progenitor cell type was identified by Hans
Clevers lab, that expresses G protein-coupled receptor Lgr5 (Gpr49) found in the antral
region of the stomach gland. These cells were identified using lineage-tracing
experiment in mice. They also claimed that the Lgr5+ cells are located at the base of
the corpus and pylorus in neonatal stomach as well (Barker et al., 2010).
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Figure 1: Anatomy of the stomach and structural features of oxyntic and pyloric
glands. The stomach is made of four regions: cardia, fundus, corpus and pylorus.
Oxyntic or corpus glands are divided into four parts: pit, isthmus, neck and base and
populated by pit cells, parietal cells, stem cells, mucous cells, endocrine cells and
zymogenic cells. The glands in pylorus contain pit cells, mucous cells, endocrine cells
and stem cells.
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Moreover, using Troy-CreERT mice, a subpopulation of zymogenic cells
expressing Troy (member of tumor necrosis factor receptor family) was identified,
located at the base of the corpus also have the ability to differentiate towards all the
mature cell types in the corpus gland (Stange et al., 2013). These cells were found to
be activated to differentiate during tissue injury caused by cytotoxic drugs (Hashimoto,
Schlessinger, & Cui, 2008).
SRY (sex determining region Y)-box 2, also known as Sox2 is highly
expressed in foregut region during the stomach development process. Sox2 is a
member of the Sox family of transcription factors and it is essential for maintaining
self-renewal and pluripotency of undifferentiated embryonic stem cells. It has also a
crucial role in maintenance of neural stem cells (Rizzino, 2009). Using genetic lineage
tracing and transplantation experiments in mice, some Sox2+ cells were also identified
as proliferating cells, located in both the corpus and antral region of the stomach
glands. These cells were capable to mature into all the cell types in the gland and
necessary for the tissue renewal (Arnold et al., 2011; Que et al., 2007).
Many previous studies have attempted to find specific markers for gastric stem
cells. A group of scientists discovered expression of Runt-related transcription factor
1 (RUNX1) in the stem cells in isthmus region of both corpus and pylorus using insito hybridization and immunohistochemistry techniques. 86% of proliferating cells in
the isthmus region were found to be RUNX1-positive (Matsuo et al., 2017). RUNX1
is a protein encoded by RUNX1 gene. It belongs to the Runt-related transcription
factor family of genes which also named as core binding factor-α (Avramopoulos,
Cox, Blaschak, Chakravarti, & Antonarakis, 1992). RUNX1 is a key regulatory
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transcription factor of hematopoiesis and involved in the generation and maintenance
of hematopoietic stem cells (Chen, Yokomizo, Zeigler, Dzierzak, & Speck, 2009).
Another marker known as Lrig1 (Leucine Rich Repeats and Immunoglobulin
Like Domains 1), was detected using a Lrig1 knock-in mouse model in the nonproliferating cells in the basal layer of the forestomach and the lower part of glands of
both corpus and pylorus. In humans, it is encoded by the LRIG1 gene (Nilsson et al.,
2001). Lrig1 was firstly identified as a marker of stem cells in the epidermis. Later
some studies showed that Lrig1 also marked inactive stem cells in intestinal and
colonic epithelium. and were found to be highly proliferative and contribute actively
to the maintenance of the tissues (Jensen & Watt, 2006; Powell et al., 2012). In the
stomach, though Lrig1+ cells were found to be non-proliferating, fate-mapping
experiments using a Rosa26-loxP-STOP-loxP-tdTomato mouse model suggested that
these cells contributed to the long-term maintenance of the gastric epithelium.
(Schweiger et al., 2018).
Moreover, one recent study suggested that stem cells self-renewal transcription
factor, octamer-binding transcription factor 4 (Oct-4) was found to be expressed in the
proliferative zone of the pylorus in normal human stomach (Al-Marzoqee et al., 2012).
Oct-4 was first discovered as an ESC-specific and germline-specific transcription
factor in mice. In humans, Oct-4 is the product of the POU5F1 gene (Okamoto et al.,
1990; Rosner et al., 1990; Schöler et al., 1990). Oct-4 belongs to the POU (Pit-OctUnc) family of proteins and it is a crucial factor involved in the self-renewal of
undifferentiated embryonic stem cells (Boyer et al., 2005). Further studies revealed
that it is also expressed in adult stem cells (adult human breast, pancreas, liver, kidney,
mesenchymal and gastric stem cells) (Tai et al., 2005). Using immunoperoxidase and
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immunofluorescence staining on human gastric tissues, it was shown that Oct-4 was
expressed in the dividing mucus-producing pre-pit and differentiating pit cells located
in the isthmus region of the pit-gland units. This evidence suggested that Oct-4 was
essential for the self-renewal of pre-pit cells and also involved in maintenance of cell
division in differentiating pit cells which progressively decreases with migration. This
was concluded based on decreasing gradient of Oct-4 expression towards the luminal
surface (Al-Marzoqee et al., 2012).
Adding to the above-mentioned markers, cluster-of-differentiation (CD44) was
also identified as a gastric stem cell marker. CD44 is a cell-surface glycoprotein that
is involved in many biological processes including cell adhesion, cell–cell interactions
and migration (Spring et al., 1988). Some studies also characterized its expression in
the normal antral epithelium (Takaishi et al., 2009) and at the squamous-corpus
junction of the mouse stomach (Ishimoto et al., 2010). Using immunohistochemical
analysis, previous studies revealed that CD44 was expressed throughout the scant
inter-glandular mesenchymal cells as well as epithelial cells within the isthmus and
also in the pit region of the glands. CD44+ epithelial cells in isthmus, were found to
be small in size and undifferentiated as they did not co-stain with markers specific for
differentiated cells (pit-specific lectin anguilla agglutinin and neck mucous cell
specific lectin GSII). In addition, the stem cell proliferation was found to be decreased
in CD44 knockout mice, which also showed defect in the number of pit cells, due to
fast turnover of the cells leading to a shortage in the gland. These altogether suggested
a crucial role of CD44 signaling in normal gastric stem cell homeostasis (Khurana et
al., 2013). Different gastric stem cell markers and their corresponding references are
provided in Table 1.
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Table 1: Gastric stem cell markers and their corresponding references
Gastric stem cell markers

References

Villin

(Braunstein et al., 2002; Qiao et al., 2007)

Lgr5

(Barker et al., 2010)

Troy

(Stange et al., 2013)

Sox2

(Arnold et al., 2011; Que et al., 2007)

RUNX1

(Matsuo et al., 2017)

Lrig1

(Schweiger et al., 2018)

Oct-4

(Al-Marzoqee et al., 2012)

CD44

(Khurana et al., 2013)

1.3.1.2 Gastric cell lineages
Different types of cells present in the gastric epithelium are described below.


Parietal cells
Parietal cells are acid-secreting cells and are developed from pre-parietal cells

in the isthmus region. Pre-parietal cells are generally characterized by long numerous
microvilli, tubulovesicles with hydrogen potassium ATPase (H,K-ATPase), increased
number of large mitochondria and few immature canaliculi. These pre-parietal cells
undergo maturation by developing increasing number of tubulovesicles, mitochondria
and gradually developing canaliculi to give rise to parietal cells within 2 to 3 days.
Parietal cells usually migrate towards both upward and downward from the isthmus
and distributed throughout the corpus glands, and the turnover time for these cells is
approximately 54 days (Karam, 1993).
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Pit cells or surface mucous cells
Stem cells in the isthmus divide and differentiate towards pre-pit cells. These

pre-pit cells then further migrate up towards the lumen and become pit cells. This
migration takes around 60 hrs. Pit cells are characterized by increased sized of
secretory granules near the Golgi apparatus, approximately double the size of the ones
present in the pre-pit cells (Karam & Leblond, 1993). The turn-over time for the pit
cells is around 3 days. Trefoil factor 1 (TFF1), a small trefoil protein co-expressed
with the gastric mucin Muc5AC in the surface mucous cells and secreted into gastric
mucus (Hanby et al., 1993; Lefebvre et al., 1993).


Mucous neck cells
Some stem cells differentiate to pre-neck cells and migrate downwards from

the isthmus to become mucous neck cells. Matured neck cells are characterized by
larger (approximately 700 nm) and higher number of mucous granules, compared to
pre-neck cells. These granules are located throughout the cytoplasm of the cells. The
turn-over time for these cells is 1 to 2 weeks (Karam & Leblond, 1993; Sato & Spicer,
1980). TFF2, another member of the trefoil factor family, holding two TFF domains,
is expressed along with the mucin MUC6 in the mucous neck cells (Hanby et al., 1993;
Jørgensen, Diamant, Jørgensen, & Thim, 1982; Lefebvre et al., 1993)


Zymogenic cells
Zymogenic cells are well known for pepsinogen secretion. They develop by

trans-differentiation of mucous neck cells when they migrate down towards the base
of the glands. The secretory granules of the mucous neck cells become larger in size
(approximately 1070 nm) and more pepsinogenic during the maturation towards the
zymogenic cells. Zymogenic cells also accumulate large amount of rough endoplasmic
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reticulum and enlarged nucleolus. The estimated turn-over time for the zymogenic
cells is 194 days (Karam & Leblond, 1993).


Endocrine cells
Endocrine cells are hormone-releasing cells. Many different types of endocrine

cells

are

present

in

the

stomach

glands

including

histamine-releasing

enterochromaffin-like cells, gastrin-secreting G cells, somatostatin-secreting D cells
and glucagon-secreting A cells and ghrelin-secreting cells. These cells scattered
throughout the gland. Endocrine cells are derived from pre-endocrine cells,
differentiated from the stem cells in isthmus (Karam & Leblond, 1992). One of the
commonly used marker specific for endocrine cells is chromogranin A (Deftos, 1991).
Details of gastric epithelial cells are presented in Table 2.

Table 2: Gastric epithelial cell types
Gastric epithelial
cell types
Parietal cells

Pit cells
Mucous neck cells
Zymogenic cells
Endocrine cells

Location

Turnover time

Specific
markers
H,K-ATPase

Scattered all
throughout corpus
glands
Pit region
Neck region

Approximately
54 days
3 days
1-2 weeks

Muc5AC, TFF1
MUC6, TFF2

Base
Scattered all
throughout corpus
glands

194 days
45-60 days

Pepsinogen
Chromogranin
A
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1.3.2 Regulation of gastric stem cell proliferation and differentiation
The gastric epithelium undergoes constant renewal process in order to maintain
long-term tissue function. Different mechanisms and factors contribute to this renewal
by regulating the gastric stem cells located in the isthmus, which actively undergo
continuous proliferation and differentiation towards other matured gastric epithelial
cells. Some of the important signaling pathways that are involved in the gastric stem
cell renewal and differentiation are notch signaling, Wnt3 signaling, hedgehog
signaling, epidermal growth factor (EGF) signaling and bone morphogenetic protein
(BMP) signaling. Several important factors related to these signaling pathways were
found to be expressed in the gastric epithelium and regulate the proliferation and
differentiation of gastric stem cells. Surface mucous cells, located at the pit region, are
generated from pre-pit cells, arise from gastric stem cells. This process is regulated by
Indian hedgehog (Ihh) and EGF (Fukaya et al., 2006; Nomura et al., 2005). The
generation and differentiation of zymogenic cells are regulated by the basic helix-loophelix transcription factor Mist1 (Ramsey et al., 2007; Tian et al., 2010). Generation of
parietal cells from pre-parietal cells derived from gastric stem cells is regulated by
sonic hedgehog (Shh), gastrin, and BMP (Shinohara et al., 2010; Stepan et al., 2005;
Wang et al., 1996).
Some previous studies have shown that the parietal cells play important role in
the gastric stem cells proliferation and differentiation. Unlike other matured cells,
parietal cells are differentiated and matured in the isthmus region without any
migration. Inhibition of parietal cell differentiation and its secretion altered the stem
cell proliferation and differentiation leading to increased number of progenitor cells
(Helander, 1995; Karam, 1993; Karam & Alexander, 2001; Li, Karam, & Gordon,

15
1995, 1996). By using laser capture microdissection, it was possible to identify some
genes expressed in parietal cells including growth hormone binding protein, vascular
endothelial growth factor-B, parathyroid hormone-like peptide, insulin-like growth
factor binding protein-2 and CD-36 are potential factors involved in the regulation of
the stem cells (Mills et al., 2001).
There are some other factors effecting stem cell regulation such as gastrin, TFF1 and
vitamin A. Previous studies have shown that gastrin, a hormone released by G cells, is
involved in the development of stomach mucosa. Deficiency of this hormone leads to
alteration in the stem cell proliferation and causes gastric adenocarcinoma in mice
(Johnson, 1988; Zavros et al., 2005). TFF1, secreted by surface mucous cells, also
affects the stem cell fate. In TFF1 knockout mice, some of the pre-parietal cells that
were committed to differentiate to parietal cells, were driven towards the pit cell
differentiation (Karam, Tomasetto, & Rio, 2004).
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Figure 2: Gastric stem cell differentiation. Stem cells are first converted to progenitor
cells which are pre-pits, pre-parietal cells, pre-neck cells and pre-endocrine cells. Then
these cells will be converted to pit cells, parietal cells, neck cells, and endocrine cells
respectively. Neck cells are further converted to zymogenic cells moving downwards
towards the base of the gland.
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Another important factor was found to have effects on the stem cell dynamics
is retinoic acid (Vitamin A). This was due to the identification of the retinoic acid
receptor in the gastric progenitor cells of mice, rabbits and human (Karam, Hassan, &
John, 2005). In addition, retinol increases parietal cell differentiation in developing
rabbits (Karam, Ansari, Al-Dhaheri, & Alexander, 2004). Some studies also showed
that retinoic acid administration increased number of S-phase progenitor cells and
enhanced differentiation towards zymogenic cells (Karam et al., 2005).
Apart from the factors mentioned above, recently scientists are gaining interest
to study effects of aryl-hydrocarbon receptor (AhR), a transcription factor expressed
in almost all types of tissues. AhR is commonly known for its xenobiotic response.
AhR was also found to be regulating stem cells in intestine (Metidji et al., 2018). Since
most the of the stem cell regulatory control factors of intestine and stomach are
interlinked through their development pathways, there might be a possibility that AhR
may have a crucial role in the gastric stem cell regulation.
1.3.3 AhR
AhR is a ligand-activated transcription factor, first discovered by Poland et al.
(1976) in mouse liver. AhR belongs to the superfamily of basic helix-loop-helix/PerARNT-Sim (Nebert, 2017), the only ligand-dependent receptor in the group. The
structure of the AhR contains three domains: one DNA binding Per-Arnt-Sim domain,
one N-terminal basic helix-loop-helix domain for ling binding and C-terminal variable
domain (Murray, Patterson, & Perdew, 2014; Stockinger, Di Meglio, Gialitakis, &
Duarte, 2014). It binds to several ligands based on its functions and expressed in almost
all types of tissues including liver, pancreas, lungs, spleen, and placenta. Moderate
expression of Ahr is also found in the brain, skeletal muscles and heart (Jiang, Wang,
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Fang, & Zheng, 2010; Spence et al., 2011). Many physiological AhR ligands such as
raw or cooked dietary components derived from fruits and cruciferous vegetables (e.g.
flavones, isoflavones, flavanones, carotenoids, glucobrassicin) and tryptophan
metabolites (e.g. kynurenine, kynurenic acid, cinnabarinic acid, xanthurenic acid)
contribute to the functions of AhR in vivo (Murray & Perdew, 2017). Numerous
environmental toxicants including polycyclic and halogenated aromatic hydrocarbons
also act as ligands that bind to AhR and facilitate transcription of target genes. Dioxin
(2,3,7,8 -tetrachlorodibenzo-p-dioxin (TCDD) having the higher affinity for AhR is
involved in most of the AhR-mediated response (Denison & Nagy, 2003). Therefore,
dioxin was chosen in this study as a ligand for AhR activation experiments.
1.3.3.1 AhR activation pathway
Inactive AhR, bound with a protein complex made of heat shock protein 90
(Hsp90), AhR-activated 9 (ARA9) and prostaglandin E synthase 3 (p23), usually
resides in the cytoplasm of the cell. Upon binding to dioxin or other ligands, AhR is
translocated to the nucleus and binds to aryl-hydrocarbon nuclear translocator (ARNT)
to form a heterodimer protein. This heterodimer complex (AhR/ARNT) further
interacts with dioxin response elements (DRE) and regulates transcription of target
genes such as cytochromes P450s, p21Cip1 and interleukin 6 (Murray et al., 2014)
(Figure 3).
1.3.3.2 AhR in stem cell regulation
Upon ligand-bound activation, AhR is involved in many biological processes
including apoptosis, cell cycle regulation (Puga, Xia, & Elferink, 2002), response to
xenobiotic stimulus and toxic substances (Ema et al., 1994), regulation of immune
response (Quintana & Sherr, 2013) and cell proliferation (Allan & Sherr, 2005).
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Figure 3: AhR signaling pathway. AhR bound to a protein complex
(Hsp90/ARA9/p23) in the cytoplasm of the cell, binds to dioxin and translocated to
the nucleus. The ligand-bound AhR further binds to aryl-hydrocarbon nuclear
translocator (ARNT) to form a heterodimer protein. This heterodimer complex then
interacts with dioxin response elements (DRE) and regulates transcription of target
genes, most commonly cytochrome P450s (CYP1A1, CYP1B1).

Some studies showed that AhR was also involved in maintenance of stem cell
homeostasis. First evidence of that was shown by studies on regulation of
hematopoietic stem cells (HSC). Different studies on effects of AhR activation on HSC
regulation were conducted: 1) use of xenobiotic AhR ligands, 2) phenotypic analysis
of knockout AhR mice, 3) studying the presence and regulation of the AhR within
HSCs, 4) examining genes regulated by the AhR pathway in conjunction with HSC
regulatory factors and 5) investigations of hematopoietic disorders. All the above
studies suggested that the AhR expression was essential for the proper maintenance of
quiescence in HSCs and AhR down-regulation was vital for “escape” from quiescence
state and subsequent proliferation of HSCs. Therefore, AhR act as a negative regulator
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of hematopoiesis restricting excessive or unnecessary proliferation of these cells,
preventing the premature exhaustion of HSCs and sensitivity to genetic alterations.
Moreover, AhR dysregulation altered the ability of HSCs to sense proper signals in the
bone marrow microenvironment leading to hematopoietic disease (Singh, Casado,
Opanashuk, & Gasiewicz, 2009).
Previous reports proposed that AhR may also have possible regulatory role on
skin stem cells. This was shown by testing effects of dioxin-activated AhR in skin of
humans and mice. Activated AhR in skin stem cells altered differentiation and
produced chloracne that led to alterations in the stimulation of stem cell into cell cycle,
increased stem cell proliferation and differentiation towards the epidermal pathway
instead of hair follicle and sebaceous gland cells (Arnold & Watt, 2001; Panteleyev &
Bickers, 2006).
Some studies have also revealed that AhR was an important regulatory factor
in neural development. These studies showed that both AHR and ARNT genes were
expressed in the embryonic neuroepithelium (Abbott, Birnbaum, & Perdew, 1995;
Abbott & Probst, 1995). AhR expression was also confirmed in neural stem cells
isolated from developing forebrain and found to be expressed in activated form in
granule neuron progenitors during neurogenesis. These data suggested that activation
of AhR may altered the stability between proliferation, differentiation, and apoptosis
in early postnatal period. Moreover, study using AhR-KO mice showed reduction in
cell numbers in the developing and adult cerebellum along with decrease in
GABAAα6 receptor expression in mature granule neurons, suggesting that AhR was
important for development and/or maintenance of neuronal cell population. Together,
these studies provided information in support of AhR contribution in neurogenesis
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through regulation of neural stem and progenitor cells (Collins et al., 2008;
Williamson, Gasiewicz, & Opanashuk, 2005).
A very recent study proposed that AhR play a significant role in intestinal
homeostasis using different transgenic mouse models (Ahr−/− mice, R26Cyp1a1,
VillinCreAhrfl/fl, VillinCreR26LSL-Cyp1a1 and Lgr5Egfp-Ires-creErt2 mice), though the
mechanism is still not known. The study found that AhR influenced the regeneration
of intestinal epithelial cells upon injury by bacterial infection or chemical treatment.
Deletion of AhR in intestinal epithelial cells resulted in failure to control the infection
due to unlimited intestinal stem cells proliferation and reduced differentiation leading
to malignant transformation. In contrast, AhR activation by dietary ligands restored
altered intestinal homeostasis maintaining the stem cell niche and prevented
tumorigenesis by controlling the inhibition of Wnt-β-catenin signaling and intestinal
epithelial cells proliferation restriction (Metidji et al., 2018).
1.3.3.3 AhR in cancer
Recently, studies have also started focusing on the role of AhR in
tumorigenesis and cancer development based on tumor mediating effects from
exposure of dioxin, one of the industrial contaminants. Dioxin exposure was first
reported to cause skin dermatitis (Tauchi et al., 2005), chloracne (Panteleyev &
Bickers, 2006) and skin cancer (Ikuta, Namiki, Fujii-Kuriyama, & Kawajiri, 2009)
through AhR activation. Moreover, AhR activation also enhanced tumorigenesis in the
liver (Barouki, Coumoul, & Fernandez-Salguero, 2007) and other organs such as
breast, lungs and prostate. Immunohistochemical studies showed that those tumors had
significantly higher AhR expression than the normal tissues (Richmond et al., 2014;
Saito et al., 2014; Su, Lin, & Chang, 2013).
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Some of the previous studies have also suggested that AhR may be linked to
gastrointestinal tumors. But this is still controversial whether it suppresses or enhances
the tumor formation in the gut. Scientists tested various mouse models and cancer cell
lines to study roles of AhR which are ligand dependent. In some colon cancer cell lines
(Caco-2, LS174T, H508, MMP9 and SN7-C4), AhR increased the cell growth and
helps in migration (Tompkins et al., 2010; Villard et al., 2007; Xie, Peng, & Raufman,
2012), whereas in others (LoVo, HCT116, DLD-1 and SW837), cell growth was
inhibited by AhR (Ronnekleiv-Kelly et al., 2016; Yin et al., 2016). Furthermore,
several studies have suggested that AhR null mice models developed increased colon
tumors indicating tumor-suppressor activity of AhR (Diaz-Diaz et al., 2016). In
addition, several stomach cancer cell lines were used to study the involvement of AhR
in gastric cancer development in the stomach. In some cell lines (MNK5 and AGS
cells), AhR promoted the growth and migration, whereas in SGC-7901 cells, it
suppressed the cell growth (Kolluri, Jin & Safe, 2017). Moreover, a transgenic mouse
model was developed with higher expression of constitutively active AhR, which
demonstrated enhanced numbers of gastric tumors indicating towards possible
oncogenic property of AhR (Andersson et al., 2002). However, it was not clear that
the effects in the transgenic models were due to any genetic error or activation of AhR
pathway. These observations altogether raise questions on the role of AhR in the
development of gastric cancer, whether it is involved in pathogenesis of the cancers or
inhibiting it. Therefore, one of the focus of this study to investigate AhR role in
stomach tissues, for which animals were injected with dioxin to activate AhR and
examined to study the effects in vivo.
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1.3.4 Gastric cancer
Gastritis is a common worldwide health problem which in severe cases give
rise to gastric cancer, the second most fatal cancer around the globe (Ang & Fock,
2014). Gastric cancers are histologically categorized into two types: welldifferentiated intestinal gastric cancer, which tend to occur more in aged people in the
pyloric region of the stomach, and undifferentiated diffuse gastric cancer, which
commonly observed in young people (Hohenberger & Gretschel, 2003). Helicobacter
pylori (H. pylori) is the common causative agent for gastritis and gastric cancer
(Nomura et al., 1991; Parsonnet et al., 1991).
Although adult stem cells are involved in the regeneration of the somatic cells,
some studies have also shown that stem cells are the major cellular source of cancer.
One of the important observations in the H. pylori-related gastric cancer is that it drives
the migration of bone marrow stem cells to the gastric mucosa and turn them into
cancer cells in the process of development of the gastric cancer (Houghton et al., 2004).
Moreover, studies on transgenic mouse expressing regulatory elements of H,KATPase beta subunit diphtheria toxin 176 have revealed that H. Pylori infection also
depended on the gastric progenitor cells in the stomach and H. Pylori can invade into
the epithelial gastric progenitor cells and form colonies in the cytoplasm, further
confirming the possible involvement of the stem cells in the gastric cancer
development (Li et al., 1996; Karam, & Gordon, 2005; Syder et al., 1999).
Moreover, studies using transgenic mouse model for gastric cancer expressing
simian virus 40 large T antigen demonstrated that inhibiting parietal cell differentiation
leads to pre-parietal cell hyperplasia and also increase in the number of other gastric
epithelial progenitors. Later at the age of 5-6 months, these mice developed gastric
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cancer with highly invasive progenitor cells which further leads to neoplasia. This
model was an indication that stem/progenitor cells contribute to cellular origin of the
neuroendocrine cancer in the stomach (Karam, Li, & Gordon, 1997; Li et al., 1995;
Modlin et al., 2005; Syder et al., 2004).
Some studies reported that the deletion of some transcription factors including
APC and Klf drives the transformation of the Lgr5+ and villin+ progenitor cells
towards cancer stem cells (Barker et al., 2010; Li et al., 2012) One of the important
potential markers identified for cancer stem cells is CD44 (Tongtawee et al., 2017).
However, previous study also suggested that even the adult cells are transdifferentiated
back to its proliferative state and develop the stem cell properties during gastric cancer
development (Guasch & Fuchs, 2005). Although, these evidences indicate possible
links between the stem cells and the gastric cancer, the mechanism underlying this
process is still not clear.
To understand these mechanisms better, scientists recently started focusing on
the metabolic pathways and the genetic factors associated with the stem cell regulation
as well as gastric cancer development. One of such important factors is the AhR. Some
current studies reported that this receptor enhances formation of tumors in many
organs including skin, liver, breast, and colon (Murray et al., 2014). Moreover, AhR
is also known for its involvement in stem cell homeostasis (Singh et al., 2009). Further,
detailed investigations on this receptor will provide insight information in
understanding the mechanism of gastric cancer development.
1.3.5 Mouse gastric stem cell line
As mentioned above, studying the biological features of gastric stem cell is
very crucial for understanding the mechanism of the gastric cancer development as
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well as defining the factors involved in this process. However, these stem cells are
relatively few and difficult to isolate, culture and maintain for biological
investigations. Therefore, production of an immortalized cell line representing the cells
will be useful. A cell line known as mouse gastric stem cells (mGS cells) (Figure 4)
was established from a transgenic mouse expressing Simian Virus 40 large T antigen
using H,K-ATPase promoter (Farook, Alkhalaf, & Karam, 2008). These cells resemble
characteristic features of gastric stem cells (Karam & Leblond, 1993). These features
include large nucleus-to-cytoplasm ratio, large reticulated nucleoli and diffuse
chromatin, cytoplasm containing many free ribosomes and a few small elements of
rough endoplasmic reticulum, mitochondria and Golgi saccules. In addition, these cells
did not have the machinery for any functional characteristics similar to differentiated
cells including secretion of acid, pepsinogen, mucus and hormones. Furthermore,
immunohistochemical analysis revealed that mGS cells neither express any markers
(H,K-ATPase, intrinsic factor, chromogranin A) specific for mature gastric cells nor
bind to lectins Griffonia simplicifolia II (GSII) and Ulex europaeus agglutinin I (UEA1) specific for mucous cells. However, these cells express stem cell markers such as
Oct-4, notch3, DCLK1 similar to mouse gastric epithelial progenitor cells (AlMarzoqee et al., 2012; Giannakis, Chen, Karam, Engstrand, & Gordon, 2008).
Therefore, mGS cells can be used as alternative to mouse gastric stem cells and as a
representative model to study features and roles in the formation of cancer. Moreover,
these cells also have the ability to grow on 3D microfibrous scaffolds (Pulikkot et al.,
2014).
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Figure 4: Mouse gastric stem cell line. A) Lower magnification phase contrast image.
B) Higher magnification image. These cells consist of large nucleus with nucleoli and
diffuse chromatin Bar=200 µm.
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1.3.6 Two-dimensional (2D) cell culture VS Three-dimensional (3D) cell culture
2D cell culture is a commonly used in vitro technique in biomedical research.
In this 2D system, cells are attached to a flat surface to form a monolayer of cells.
However, culturing cells in 3D has been attracting researchers over the years and
seemed to be closer to in vivo systems than 2D. These 3D culture systems have been
used as biological model for testing drug activity and study several human diseases
including cancer and microbial infections (Fatehullah, Tan, & Barker, 2016; Hill &
Spence, 2017). Recently, 3D culture models, known as 3D spheroid/organoids, have
become a major scientific progress and an important tool in biological and clinical
studies (Figure 5).
Organoids are 3D structures that are generated from stem cells to mimic in vivo
organs both structurally and functionally (Lancaster & Knoblich, 2014). In the term
organoid, ‘oid’ came from the Latin ‘oides’ which means resemblance. Three types of
cells that are commonly used to grow organoids are: embryonic stem cells, induced
pluripotent stem cells and organ specific adult stem cells. This 3D model helps to study
many in vivo biological processes including stem cell functions and effect of mutations
(Fatehullah et al., 2016). This can also be applied for regenerative medicine studies.
Different types of organoids have been developed from numerous cell types such as
stomach cells, liver cells, neural cells, pancreatic cells, and intestinal cells.
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1.3.7 3D Organoids
1.3.7.1 History of development of 3D organoids
Organoid cultures were evolved historically over many years. The first attempt
to mimic tissues in vivo was done by Ross Harrison in 1906 through hanging drop
method to study the origin of nerve fibers.

Figure 5: Illustration of 2D and 3D cell culture. A) In 2D culture, cells form a
monolayer on the surface, growing and connecting to each other. B) In 3D culture,
cells immersed in matrix, grow in its own dimensional way and start creating their own
environment to achieve a structure mimicking the in vivo organs.

In this method, a piece of nerve cord from embryo was kept on a drop of lymph on
coverslip and was then inverted and sealed over an excavated slide. This hanging drop
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of lymph environment allowed the nerve fiber to grow (Horrison, 1906). In 1907,
Wilson proved that the detached sponge cells can re-aggregate into a whole organism.
Later, “tube culture method” (growing tissues in tubes) (Strangeways & Honor, 1926)
was developed along with “watch glass method” (Fell & Robison, 1929) in which
tissue fragment was cultured on plasma clot on concave glass surface placed in petri
dish filled with wet cotton. Ehrmann and Gey in 1956 showed that cells grew and
survived well on collagen (Ehrmann & Gey, 1956). Lasfargues in 1957 generated first
mammary organoids using collagenase to dissociate adult mouse mammary gland
tissue. Moscona in 1959 showed that cells growing in suspension form tissue like
structures by clumping together (Moscona, 1959). In the meantime, Richard Swarm
and group (1963) prepared a gel called Engelbreth-Holm-Swarm (EHS) sarcoma that
mimicked the basement membrane which is nowadays frequently used and named as
matrigel (Kleinman & Martin, 2005). Matrigel contains laminin (Timpl et al., 1979),
collagen, fibronectin, and entactin. In 1988, Bissell and colleagues generated 3D ducts
and ductules from breast epithelial cells on EHS sarcoma (Li et al., 1987). In 2008,
Sasai and group used pluripotent stem cells to grow 3D cerebral cortex tissue by using
serum-free culture of embryoid body-like aggregates method (Eiraku et al., 2008).
1.3.7.2 Methods to develop organoids
Different types of methods have been established for developing 3D organoids
based on nature and architecture of cells or tissues to mimic the in vivo system as close
as possible. Some of the common methods that we have used in this study are described
below.
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Hanging drop method
Harrison (1906) first came up with the hanging drop method to grow nerve

fibers on lymph drops (Horrison, 1906). This method was further modified by Kelm
et al. (2003) to form 3D organoids through hanging a drop of cell-containing media.
Kelm and group seeded cells in different densities on 60-well MicroWell MiniTray
and inverted the tray to hang the drop of cell suspensions leading to gather at the
bottom of the drops to forms 3D structures (Kelm, Timmins, Brown, Fussenegger, &
Nielsen, 2003). These drops stay at hanged position due to surface tension. This
method was later done on 60-mm petri dishes. Moisture levels of the drop were
maintained by filling the bottom lid with PBS. Nowadays there are 3D hanging drop
plates that are commercially available such as gravity plus or 3D perfecta, for growing
organoids for longer period of time, but they need to be transferred to non-adherent
plates for analysis or to grow for further studies.


Force-floating method
In this method, cells are forced to grow on suspension on a surface that is

modified to prevent their attachment. As a result, cells aggregate to form spheres (Lin
& Chang, 2008). Ivascu and Kubbies in 2006 used this method to grow organoids from
both cancer and non-cancerous cells by coating the surface of 96-well plates (both
round and conical) with 0.5% poly-2-hydroxymethyl methacrylate. This coating
prevented the cells from attaching to the surface and helped them clump together to
form 3D organoids (Ivascu & Kubbies, 2006). Although some organoids did not form
compact structure, but this problem was resolved by adding 2.5% liquid reconstituted
basement membrane to media. The well plates can also be coated with 1.5% agarose
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to prevent cell adhesion to the surface. The non-adherent plates are now commercially
available.


Matrigel technique
Generally, epithelial cells communicate with nearby cells and extracellular

matrices (ECM) to organize themselves into tissues. As ECMs along with basement
membrane plays important role in cellular structure and function, its use in 3D culture
showed better results mimicking in vivo conditions. Current well-known example is
matrigel, which contains basement membrane proteins such as laminin, collagen IV,
matrix metalloproteinase-2, perlecan, entactin, and some growth factors (Kleinman &
Martin, 2005).
1.3.7.3 Types of organoids developed
So far different kinds of organoids have been derived from stem cells. Some of
them are discussed below.


Brain organoids
Brain organoids were grown from neural stem cell, induced pluripotent stem

cells and also by using pluripotent stem cells (PSCs). Briefly, PSCs can be used to
grow brain organoids with minimal media conditions. First the cells differentiate into
neuroectoderm, then grown in 20% KSR media (Knockout serum replacement) give
rise to neuroepithelium. These neuroepithelium are then transferred to matrigel and
agitated in bioreactors for further growth and development into brain organoids
(Lancaster & Knoblich, 2014). Watanabe et al. (2005) first showed that murine
embryonic stem cells (mESCs) when grown on serum-free culture SFEB (serum-free,
floating culture of embryoid body-like aggregates) aggregate and differentiate into
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telencephalic precursors (Watanabe et al., 2005). Altering growth factors of the media
may give rise to many other regions of the brains such as sub pallial patterning and
adeno-hypophysis (Danjo et al., 2011; Suga et al., 2011). Scientists were also able to
develop single brain organoid with multiple brain regions (Lancaster et al., 2013).
During the ectoderm stage of organoid development, the differentiation can be diverted
to retinal epithelium using 1.5% KSR and transferring them to 2% matrigel that will
give rise to optic cup organoid (Lancaster & Knoblich, 2014).


Kidney organoids
Throughout the past few years, different protocols have been tried to generate

kidney organoids from embryonic stem cells, but those were not proved applicable for
research purposes. Researchers later studied different growth factors including retinoic
acid (RA), bone morphogenic protein (BMP), and fibroblast growth factor (FGF) that
play major role in differentiation, development and repair of kidney, which were later
used to establish an appropriate protocol for developing kidney organoids (Kim &
Dressler, 2005). Briefly, kidney organoids were derived from PSCs in media
containing various growth factors such as activin A which converts PSCs to
mesendoderm. Mesendoderm was then differentiated towards kidney organoids with
the addition of BMP, FGF9, and retinoic acid (Lancaster & Knoblich, 2014).


Liver and pancreas organoids
Liver and pancreas organoids were generated from leucine-rich repeat-

containing G-protein coupled receptor (Lgr5)+ hepatic and pancreatic stem cells
respectively, which share genetic similarity with intestinal Lgr5+ stem cells. Thus
using the R-spondin based culture system (media with R-spondin, FGF, Noggin etc.)
established by Sato and Clevers for intestine organoids development (Sato & Clevers,
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2013), researchers showed that the organoids can be differentiated into matured,
functional hepatocytes (Huch et al., 2013). Later, liver organoids were finally
generated on matrigel along R-spondin based media which have functional similarities
to in vivo hepatocytes (Huch et al., 2015). Furthermore, previous studies showed that
the Lgr5+ stem cells from both pancreas and liver are functionally and phenotypically
similar (Dorrell et al., 2014). Therefore, these cells can be differentiated towards either
pancreas or hepatocytes by altering culture conditions. Liver organoids were also
generated from PSCs through activin A treatment which gave rise to hepatic cells.
These cells combined with mesenchymal and endothelial cells formed 3D organoids
(Takebe et al., 2013).


Intestinal organoids
Intestinal mucosal epithelium is composed of glandular folding known as

crypts (downward) and villus (upward) respectively that are made of single layer
simple columnar cells. Intestinal homeostasis is preserved by the rapid self-renewal of
stem cells that express Lgr5 (Barker et al., 2007) lying at the base of crypt capable of
dividing and differentiating to renew cells in the intestinal tissue. Sato et al. first used
a culture media cocktail consists of R-spondin-1, noggin, and FGF associated with
matrigel to culture intestinal crypts or Lrg5+ stem cells (Sato et al., 2009). R-spondin1 is the ligand for Lgr5 receptor which together enhance Wnt-signalling (pathway
required for stem cell proliferation and maintenance) (de Lau et al., 2011; Pinto,
Gregorieff, Begthel, & Clevers, 2003; Sato, Stange, et al., 2011). Following the same
culture system, Sato and Clevers generated intestinal organoids from Lrg5+ stem cells
derived from intestinal tissue (Sato & Clevers, 2013). However, Lrg5+ stem cells were
quiescent, slowing the organoids formation. So, it was recommended to grow
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organoids from whole crypt gland or co-culturing Lrg5+ stem cells with Paneth cells
that express EGF and Wnt3, and thus forming organoids with all the differentiated
matured intestinal cells (Sato et al., 2011; Sato et al., 2009). In case of colonic
organoids, Wnt3 should be added to the media as colon crypts lacking the Paneth cells
(Sato, Stange, et al., 2011). Furthermore, intestinal organoids were also generated from
PSCs. First PSCs were treated with activin A to generate hindgut organoids and then
the organoids were cultured in matrigel overlaid with R-spondin-conditioned media
cocktail (Spence et al., 2011).


Stomach organoids
Similar to intestinal stem cells, the pyloric stem cells of stomach express Lrg5.

Thus, a similar protocol with some modifications was used to generate stomach
organoids from Lrg5+ stem cells. Organoids were also developed from Troy+
zymogenic cells found at the base of corpus glands (Barker et al., 2010; Stange et al.,
2013). For human gastric organoids, factors such as epidermal growth factor (EGF),
Wnt, and R-spondin were added to the culture media (Bartfeld et al., 2015), while for
mouse gastric organoids, Noggin, fibroblast growth factor (FGF10), and gastrin were
used (Schumacher et al., 2015). Although these organoids were shown to have matured
stomach cells such as mucous neck cells, endocrine cells, zymogenic cells, and pit
cells, however they lack parietal cells indicating that there was still something missing
in the culture system. Schumacher et al. tried co-culturing organoids with stomach
mesenchymal stem cells and were able to differentiate towards all types of cells
(Schumacher et al., 2015). Stomach organoids were also grown from PSCs. Briefly,
PSCs were treated with Activin A to develop into definitive endoderm by day 3. This
further was converted to posterior foregut organoid upon treatment with growth factors
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such as Wnt, FGF4, Noggin, and retinoic acid (RA) by day 6, which was then further
differentiated towards antral region with the withdrawal of Wnt up to day 9. Finally,
the organoids were grown and differentiated up to 34 days with media containing only
EGF (McCracken et al., 2014). All the previous protocols used to develop gastric
organoids from PSCs were towards antral region missing the parietal cells. Recently.
McCracken and his group showed that stem cells in the gastric organoids can also be
differentiated towards parietal cells of the corpus region. After studying different
signaling pathways including Wnt/β catenin pathway and MEK-pathway that are
involved in stomach growth and development during embryonic stages, this study
tested if modifying any of these pathways have any effect on the growth of the stomach
organoids. Then, it was suggested by the study that the activation of β catenin by
GSK3βinhibitor

CHIR99021

(CHIR)

and

inhibiting

MEK-pathway

with

PD0325901(PD03) drive the stem cell differentiation towards parietal cells (corpus)
in the organoids (McCracken et al., 2017).
1.3.7.4 Applications of organoids
The fact that the cells in the organoids organize themselves to mimic in vivo
organs, it makes them excellent models to be applied in the study of many important
fields far better than using usual 2D cell culture. Organoids are used in many studies
including tissue regeneration, disease modeling, drug testing, organ morphogenesis
and development and host pathogen interactions.
Organoids can also be a useful model for stem cell research. Since, stem cells
are the main source for organ development and nowadays it is also believed that stem
cells are involved in pathogenesis of some diseases like cancer, it is a highly
demanding research field, but it is very challenging because of difficulty in isolating
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and culturing stem cells. Therefore, 3D organoids will help in better understanding in
the stem cell functions and factors regulating them as these organoids mimic in vivo
organs far better than the usual 2D cell cultures.
1.4 Aims of this study
The first aim of this study was to develop 3D organoids from mGS cells. mGS
cells have typical epithelial cell appearance and also have characteristic features
resembling the gastric stem cells. Therefore, in this study, the mGS cells were tested
for the capacity to develop organoids as these cells somewhat morphologically
resembles the gastric epithelial progenitor cells.
The second aim was to develop organoids from neonatal mouse gastric glands
and label the dividing cells by bromodeoxyuridine. Then the organoids at different
time points were followed to test whether the stem cells are involved in the
development of the organoids. The organoids were characterized using,
immunohistochemistry and electron microscopy and tested for differentiation towards
the stomach cell lineages.
The fourth aim was to investigate the expression of AhR in gastric epithelial
cells, tissues and organoids.
This fifth aim was to investigate effects of dioxin-activated AhR on mouse
stomach tissues and organoids. Finally, AhR expression was investigated in human
stomach tissues.
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Chapter 2: Methods

2.1 Development of 3D organoids from mGS cells
In this experiment, the hanging drop method was used to grow organoids from
mGS cells, followed by force-floating method. Then the cells in the organoids were
characterized using cell viability assays and electron microscopy.
2.1.1 Mouse gastric stem cell culture
Mouse gastric stem cells were maintained in Roswell Park Memorial
Institute (RPMI) media (Thermo Fisher Scientific, USA) containing 10% fetal bovine
serum (FBS) (Thermo Fisher Scientific, USA) in a humidified chamber at 37ºC with
5% carbon dioxide (CO2). Cells were passaged every four days when 70-80%
confluence. Briefly, media was removed, cells were washed with phosphate buffer
saline (PBS) (Thermo Fisher Scientific, USA), cells were incubated in trypsin,
collected in a 15 ml tube and centrifuged. Cells were transferred into new flask
containing fresh media and incubated in CO2 incubator. The media was changed every
third day.
2.1.2 Formation of organoids by hanging drop method followed by
force-floating technique
Cells were grown to 70-80% confluence and trypsinized, followed by
centrifugation and removal of supernatant. Total live cells were counted using
hemocytometer, and 500 or 1000 cells were used for each hanging drop experiment.
In short, the 90 mm petri dish bottom was filled with 10 ml PBS and the upper lid was
used for hanging drops, which contained 20 µl of cell suspensions in RPMI media,
supplemented with 10% FBS. The whole set up was then incubated in humidified CO2
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incubator at 37ºC. The drops were monitored daily and incubated until cell aggregates
were formed. Once spherical organoids were formed, they were washed with fresh
media and transferred to agarose (1.5%) coated 96-well plates for growth and
development (Figure 6).
2.1.3 Cell Viability assay
Media from the organoid culture plates was removed following PBS wash.
Organoids were incubated for 15 mins in calcein (3 µM) (Molecular Probes, USA) and
then for 15 mins in propidium iodide (2.5 µM) (Molecular Probes, USA). Calcein was
used for detecting live cells and propidium iodide (PI) for dead cells. Then the
organoids were imaged by inverted phase contrast microscope (Olympus IX71, Japan)
or confocal microscope (Nikon Eclipse Ti, Japan).
2.1.4 Transmission electron microscopy (TEM)
To detect ultra-structural features of cells forming organoids the electron
microscopy was used. Organoids were fixed with Karnovsky’s fixative with 0.2%
tannic acid for 30 mins and washed with 0.1 M sodium cacodylate (3 times for 10 mins
each) followed by 1-hour incubation with 1% osmium tetroxide. Organoids were then
washed with distilled water for 3 times (2 mins each). Then the organoids were
dehydrated with ascending grades of ethanol series (30%, 50%, 70%, 80%, 90%, 95%,
and 100% for 15 mins each), and embedded using resin. Sample on resin blocks were
sectioned (ultrathin approximately 100 nm) and stained with uranyl acetate followed
by lead citrate. Finally, organoids were visualized using electron microscope (Tecnai
G2 Bio Twin, Holland).
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Figure 6: Hanging drop technique followed by force-floating method. mGS cells were
cultured and extracted when approx. 80% confluence and seeded in RPMI media drops
(8 µl) hanging on the upper cover of the petri dish, the bottom was filled with PBS.
After 5 days, organoids were transferred to agarose coated plates to grow and analyze
them further by cell viability assays and electron microscopy.
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2.2 Development of 3D organoids from neonatal mouse gastric glands
2.2.1 Animals
All the in vivo experiments in this study were carried out using C57BL/6J
mouse strain provided by the animal house, United Arab Emirates University. Mice
were kept and maintained under special germ-free conditions at a constant temperature
of 22±3°C, 55% relative humidity, on a 12-hours light/dark cycle and regular food and
water supply.
2.2.2 Isolation of neonatal mouse stomach glands
C57BL/6 mice of 5 days old were used to isolate stomach glands. Mice were
sacrificed and the stomach was quickly excised using scissor and cut along the greater
curvature. Stomach was washed with cold PBS several times and cut into small pieces
of approximately 1 mm. Tissue pieces were then washed with cold PBS and then
washed with buffer containing 96.2 mM NaCl, 54.9 mM D-sorbitol, 8.0 mM KH2PO4,
5.6 mM NaHPO4, 43.4 mM sucrose, 0.5 mM DL-dithiothreitol, in deionized water).
Then the tissue pieces were incubated with chelating buffer containing EDTA (2 mM)
for 30 mins at 4°C on a rotating platform. The buffer solution was removed, tissue
pieces were placed in a petri dish and gently pressed with a glass slide to separate the
gastric glands. Glands were then re-suspended in advanced Dulbecco’s modified Eagle
medium/F12 (DMEM/F12) (Thermo Fisher Scientific, USA) medium containing 10%
FBS, collected in a 15 ml tube and large tissue pieces were allowed to settle at the
bottom. Supernatant containing the isolated glands was transferred to a new tube and
centrifuged (250×g, 5 mins). The isolated glands were then used for the formation of
organoids.
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2.2.3 Development of gastric organoids from gastric glands
Matrigel was thawed at 4°C and 24-well plates were pre-warmed at 37°C.
Isolated gastric glands were pelleted down and resuspended with ice-cold matrigel
(growth factor reduced, phenol red free) purchased from Corning, USA and seeded in
pre-warmed 24-well plates (50 μl per well). The matrigel containing glands was
allowed to solidify for 15 mins at 37°C and then covered with 500 ml 10% DMEM/F12
medium supplemented with several growth factors: murine Wnt3A (Peprotech, UK),
R-spondin 1 (R & D systems, USA), 2% B27 supplement without vitamin A (Thermo
Fisher Scientific, USA), 1% N2 supplement (Thermo Fisher Scientific, USA), 50
ng/ml epidermal growth factor (Peprotech, UK), 150 ng/ml noggin (Peprotech, UK),
100 ng/ml fibroblast growth factor (Peprotech, UK), 1.25 mM N-acetyl-L-cystein
(Sigma-Aldrich, USA), 10 nM gastrin (Sigma-Aldrich, USA) and 10 µM Y-27632
(Sigma-Aldrich, USA). Matrigel containing glands were maintained in a humidified
incubator at 37°C, 5% CO2. When the organoids were developed, media was changed
every other day without Y-27632, it is only required at the initial days for saving the
cells from dying when getting separated from extra cellular matrix (Figure 7).
2.2.4 Bromodeoxyuridine (BrdU) labelling of organoids
Neonatal mice were injected with BrdU (120 mg/kg) intra-peritoneally. After
two hours of injection, mice were euthanized and some stomachs were used for
organoid formation and few stomachs were processed for microscopic analysis.
Organoids of different time points were processed for paraffin embedding and
microscopic examination.
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Figure 7: Generation of organoids from neonatal gastric glands. 4 days old mice were
dissected, stomach was cut opened and cut into small pieces. Tissue pieces were
washed, incubated in chelating buffer with EDTA, pressed between a slide and a petri
dish and collected using DMEM/F12 media. The media was collected, centrifuged,
supernatant containing glands were seeded in matrigel. Media was added after the
matrigel was solidified and kept in humidified incubator at 37°C.
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2.2.5 Histological characterization of the organoids
2.2.5.1 Processing of organoids for microscopic examination
The organoids in matrigel were fixed in 4% paraformaldehyde (PFA) in PBS
at 4ºC for 2 hours. Liquified matrigel was gently removed and organoids were
transferred to a 1.5 ml centrifuge tube, pre-warmed histogel (Thermo Fisher Scintific,
USA) at 60°C was added to the tube. The histogel with organoids was then solidified
and rapped in a thin filter paper and transferred to tissue processing cassettes. The
histogel containing organoids were then fixed in 10% formalin for 2 hours and
dehydrated in ethanol series (50% for 30 mins, 70% for 30 mins, 80% for 30 mins,
90% for 1 hour, 100% for 2 hours), 1 hour incubation in isopropanol and 2 hours in
acetone followed by overnight infiltration in paraffin at 54°C. Then they were
embedded in paraffin, sectioned (5 µm) and mounted on gelatin-coated slides (Figure
8).
Histogel paraffin sections containing organoids were dewaxed by incubating at 60ºC
for 10 mins followed by incubation in xylene twice for 5 mins each. Then the sections
were rehydrated with a descending series of alcohol 100% (twice for 3 mins), 95%,
90%, 70%, 50%, 30% (3 mins each) and further steps were followed according to
staining procedure (Figure 8).
2.2.5.2 Periodic-acid Schiff and hematoxylin staining
Hydrated sections of organoids were incubated in periodic acid solution
(Abcam, Cambridge, UK) for 5 mins following few washes with tap water, sections
were incubated with Schiff reagent for 15 mins. Then hematoxylin solution (Thermo
Fisher Scientific, USA) was added for 1 min and sections were washed with tap water
and dehydrated with series of alcohol (70%, 90%, 100% twice, for 3 mins each) and
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incubated in xylene twice for 5 mins each. The slide was finally mounted with DPX
and covered with coverslips.

Figure 8: Processing of organoids using histogel for microscopic analysis. Organoids
were fixed in 4% PFA, separated from matrigel and embedded in melted histogel. Then
histogel containing organoids was placed in a cassette and whole set was then
processed for microscopic analysis.
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2.2.5.3 Immunostaining
Rehydrated sections of organoids were washed with PBS three times for 5 mins
each. Sections were incubated in PBS containing 1% Bovine Serum Albumin and 0.5%
Tween-20 to block the non-specific binding sites for 45 mins, followed by incubation
with primary antibodies for 1hour or overnight at 4ºC. Primary antibodies used for
organoids were mouse monoclonal anti H,K-ATPase β-subunit (Medical and
Biological Laboratories Co. Woburn, MA, USA), E-cadherin, anti-pepsinogen C
(Abcam, UK), Chromogranin A (Abcam, UK). Sections were then washed with PBS
and incubated with secondary antibody, goat polyclonal anti-mouse (Alexa Fluor 488
conjugated) (Abcam, USA) for 1 hour (1:500). For nuclear staining, some of the
sections were stained with propidium iodide prepared in PBS (1:10000) for 1 min.
Sections were then washed several times with PBS for 5 mins each and mounted with
mounting media. Florescent signals in the immune-stained sections, reflecting antigenantibody binding sites were visualized by confocal microscope (Nikon Eclipse Ti,
Japan).
2.2.5.4 Immuno-peroxidase staining
After dewaxing and rehydration, organoid sections were washed with PBS, and
incubated with 3% hydrogen peroxide (H2O2) prepared in methanol for 30 mins to
inhibit endogenous peroxidases. Sections were then washed with PBS, blocked by
incubating in 1% BSA. Then the sections were incubated with primary antibody mouse
monoclonal anti-BrdU antibodies (Medical and Biological Laboratories Co., Nagoya,
Japan) or mouse monoclonal anti-AhR antibody (Santa Cruz Biotechnology, USA).
Following, washing with PBS three times 5 mins each, sections were incubated with
biotinylated polyclonal anti-mouse secondary antibody (1:500) (Jackson Immuno
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Research Laboratories, USA) for 1 hour. The substrate Extravidine peroxidase
conjugate (Sigma, St. Louis, MO, USA) prepared in 1% BSA (1:1000) was added for
1 hour and then washed with PBS. Antigen-antibody bindings were then visualized by
adding 3’3’-diaminobenzidene (DAB) (Sigma, St. Louis, MO, USA). The section was
then washed with distilled water. Then the sections were dehydrated through a series
of increasing concentrations of alcohols, 70%, 90%, 100% twice for 3 mins each and
immersed in xylene twice for 5 mins and finally mounted with Dibutylphthalate
Polystyrene Xylene (DPX) mounting medium. The sections were finally visualized,
and the images were captured by Olympus light microscope connected to DP70 digital
camera.
2.2.5.5 Lectin histochemistry
The sections of organoids were deparaffinized, rehydrated and washed with
PBS 3 times for 5 mins each. Then the sections were blocked in 1% BSA with 0.5%
Tween-20 in PBS for 45 mins. Then sections were incubated with rhodamineconjugated fucose-specific UEA-1 lectin (Vector Laboratories, USA) for 1 hour
followed by washing with PBS three times for 5 mins each. Then the sections were
incubated with Alexa Flour 488 conjugated Wheat germ agglutinin (WGA) (Thermo
Fisher Scientific, USA) and washed with PBS 3 times (5 mins each). Some sections
were stained with propidium iodide for nuclear staining Finally, sections were
dehydrated and mounted with mounting media and imaged by the confocal
microscope.
2.2.6 Reverse Transcription Quantitative Polymerase Chain Reaction (RT qPCR)
Firstly, media from the organoids at different time points (2, 4, 10 days) was
removed and washed with cold PBS. Matrigel was melted in cold PBS and removed.
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The organoids were lysed with TRIZOL Reagent (Ambion) by repetitive pipetting and
kept at room temperature for 5 min to allow dissociation of nucleoprotein complexes.
Then, 200 μl chloroform was added to the sample and shaken vigorously for 10
seconds. Samples were then incubated at room temperature for 5 mins and centrifuged
at 13000 revolutions per minute (rpm) for 15 mins at 4°C. The aqueous phase
approximately 200 μl was removed using a micropipette and equal volume of
isopropanol was added to precipitate the RNA. Tubes containing RNA solution were
inverted until the solution was clear and incubated at room temperature for 10 mins
and then the samples were centrifuged for 15 mins at 13000 rpm at 4°C. The
supernatant was removed and washed with 1 ml of 75% ethanol prepared in nucleasefree water. Samples were centrifuged at 10000 rpm at 4°C (5 mins), the ethanol was
poured off and the pellet was left to air dry. 20 µl nuclease free water was added to
each tube and incubated at 55-60°C for 10 mins in a water bath. RNA samples were
then stored in -80ºC for 24 hours.
The RNA was quantified using a Nanodrop 2000 spectrophotometer (Thermo
scientific, USA). Firstly, 1μl of nuclease free water was added on the platform as blank
and then 1 μl of RNA samples were added. The concentration per 1 µl of sample was
noted. Total RNA purity was taken as a value from 1.9 to 2.00 at 260 nm/280 nm ratio.
Next, a High-Quality cDNA Reverse Transcription kit (Applied Biosystems,
Ludhiana) was used for cDNA synthesis. Reverse transcriptase master mix was
prepared by adding appropriate volume of 25x deoxyribonucleotide triphosphates
(dNTPs), 10x reverse transcriptase (RT) buffer, Multiscribe™ reverse transcriptase,
10x Random Primers and RNAase inhibitor. Then nuclease free water and RNA
templates were added to the master mix for each sample. These mixtures were then
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centrifuged to spin down the contents and to remove any air bubbles formed. Then the
samples were incubated at 25°C for 10 mins, 120 mins at 37°C and 5 secs at 85°C on
a Thermocycler and the cDNA samples were stored at -20°C.
Synthesized cDNA was used as template in PCR. qPCR was performed using
SyBR green master mix, which was prepared by adding forward and reverse primers,
Nuclease free water and SYBER green (2X SYBER® Select Master Mix, Applied
Biosystems, USA). The master mix was then added to the 96-well plate and 0.5 μl of
cDNA (contains 25 ng cDNA) was added to each well (samples were duplicated). The
plate was then sealed with adhesive cover and centrifuged to remove any air bubbles
and spin down the DNA samples. The PCR machine (Quant Studio 7 Flex, Applied
Biosystems, USA). PCR was conducted for 40 cycles each consists of 95ºC
denaturation and 60ºC for annealing and extension. The Ct values obtained from the
PCR machine (Quant Studio 7, Applied Biosystems) were used to analyze the
respective mRNA expressions with respect to the house keeping gene Glyceraldehyde
3-phosphate dehydrogenase (GAPDH). For quantification, Delta Ct (threshold cycle)
values were calculated by CT target-CTGAPDH. DATA were expressed as 100x2ΔCt
in order to express the difference in cycles to cross the threshold as a percentage. The
list of primers used are provided in Table 3.
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Table 3: List of primers used for RT-qPCR

Gene

Primer

Sequence (5’-3’)

Muc5

Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

AGGGCCCAGTGAGCATCTCCTA
CATCATCGCAGCGCAGAGTCA
CCCGGGAGAGGATAAATTGT
GCCAGTTCTCTCAGGATGGA
CTCACCTTCTACCCCAGTATCA
GGCAACGAG TTAGAGTCACATT
GCAGTGCTTTGATCTTGGATGC
TCAGGTTGGAAAAGCAGCAGTT
AACAGAATTGTCAAGTTCCTC
AGACTGAAGGTGCCATTG
GCAGCATCCAGTTCCCACTTCC
TCCCCATCTTCCTCCTGCTGAG
CGCTGAAACATGAGCAAATTG G
ACAGCTTAGGTGCTGAGTCACAGG
ACAGCTGCCCCACATACAAC
GGGATGGTAGGCTGTGTCA
GGCAACTAACTGCTGGAACT
CTCATCTTGCCGGGGCTCAG
CAAGGTCCTACCTCTACACA
AAGGTTCACCTTGCTGGTAC
GTTCTGCGGAGGGATGGCATAC
AAGGCCTCGAAGCGACAGATG
TCGATTTGAATGTAACCTGCCG
CAGTCCGGGAGATACTGTAGC
TGTCAGATGATAAGGTCATCACG
TCTCCAGAATGAAGGCCTCCAG

Forward
Reverse

TCAAGAAGGTGGTGAAGCAGG
TATTATGGGGGTCTGGGATGG

TFF1
MUC6
TFF2
H,K-ATPase β
CgA
AhR
Lrig 1
RUNX1
Troy
Oct-4
CD44
CYP1A1
GAPDH

2.3 Testing effects of dioxin-treated AhR activation in 3D primary organoids
Gastric organoids from neonatal mouse were seeded in matrigel and grown for
two days as mentioned before. At day 2, the old media containing growth factors was
changed with fresh media containing dioxin (0.1 nM and 1 nM) along with all the
growth factors and hormones needed for the organoid growth. Organoids were

50
monitored using phase contrast microscope (Olympus IX71, Japan). After two days of
treatment organoid were collected at day 4 and processed for microscopic studies and
also collected for PCR. Images were taken using confocal microscope.
2.4 Testing effects of dioxin-treated AhR activation in vivo
2.4.1 Dioxin treatment on mice
Recently weaned 21 days old male mice (n=3) were injected daily with dioxin
(50 µg/kg), (prepared in dimethylsulfoxide (DMSO) and diluted in PBS) intraperitoneally for three consecutive days and sacrificed on day four. Control mice (n=3)
received only vehicle. The mice were euthanized, and the stomachs were cut opened
through greater curvature, washed with cold PBS. Small portion of the stomach was
cut longitudinally and kept in the RNA later (Ambion, USA) for RT-qPCR. The
samples were then kept at -80°C for further studies. Rest of the tissue portion was fixed
and processed for light microscopy.
2.4.2 Tissue processing for light microscopy
The control and dioxin treated stomach tissues were fixed overnight in Bouin’s
solution, dehydrated in ethanol series (70% for half an hour, 90% for 1 hour, 100% for
2 hours twice). Then the tissues were taken under the fume hood and incubated in
xylene: ethanol (1:1) and xylene (30 mins twice). Tissues were then embedded in
melted paraffin (at 54ºC) for 1hour. This step is done thrice using fresh paraffin each
time to replace the xylene completely from the tissues. Then the tissues were placed
in tissue processing molds filled with melted paraffin longitudinally to get the section
of whole gastric glands. When the paraffin was solidified, tissues were sectioned (5
µm) using automated rotatory microtome machine. The sections were then floated on
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water bath at 45ºC. Tissue sections were then mounted on gelatin-coated slides and
left to dry on hotplate at 60ºC (20 minutes) and stored for further use.
2.4.3 Immuno-staining on stomach tissues
For immuno-peroxidase staining, sections were deparaffinized (incubated in
xylene twice for 5 mins each), rehydrated in decreasing alcohol series (100% twice,
95%, 90%, 70%, 50%) for 3 mins each and incubated in 3% H2O2 (in methanol) for
30 mins to block endogenous peroxidases by incubating in 1% BSA. Then the sections
were incubated for 1 hour or overnight with primary antibody against AhR (Santa Cruz
Biotechnology, USA), mouse monoclonal anti H,K-ATPase β-subunit (Medical and
Biological Laboratories Co., Woburn, MA, USA) and anti-BrdU (Medical and
Biological Laboratories Co., Nagoya, Japan) followed by washing with PBS (3 times
for 5 mins each) and incubation in biotinylated secondary antibody for 1 hour. Then
the sections were washed with PBS. The substrate extravidine peroxidase conjugate
(Sigma, St. Louis, MO, USA) was added for 1 hr. Then, DAB was added after washing
with PBS and color development was monitored with the microscope. Sections were
then washed with distilled water, dehydrated with increasing grades of alcohol series
(70%, 90% and 100% twice), 3 mins each and incubated in xylene twice for 5 mins
each. Sections were finally mounted with dibutylphthalate polystyrene xylene (DPX)
(Sigma-Aldrich) and visualized with Olympus light microscope.
2.4.4 Lectin histochemistry
For lectin histochemistry, sections were deparaffinized, rehydrated, washed
with PBS and blocked by incubating in 1% BSA for 1 hour. Then sections were
incubated in rhodamine conjugated UEA-1 for 1 hour followed by washing with PBS
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(3 times, 5 mins each). Then the tissue sections were incubated in the second lectin
Griffonia simplicifolia II (GSII) conjugated with Alexa Flour 488 (Thermo-Fisher
Scientific, USA) and washed thrice with PBS for 5 mins each. Sections were imaged
by confocal microscope. It is established that UEA-1 binds to fucose-rich surface
mucous cells and GSII is specific for N-Acetyl-D-glucosamine-rich mucous neck cells
in the tissues. After washing, sections were mounted with fluoro-shield mounting
medium 4',6-diamidino-2-phenylindole (DAPI) (Abcam, Cambridge, UK)
2.4.5 Quantitative analysis of labelling intensity
The images of the tissues were taken using the Olympus DP70 microscope.
The labelling intensities of UEA-1 and GSII lectins were calculated using the Fiji
ImageJ software. Images were taken at 40x magnification. The corpus area next to the
fundus was selected for analysis. The images obtained from control and dioxin-treated
tissues were compared side by side using ImageJ densitometric software for analysis.
Then, the images were converted to 8-bit, and pixel density was calculated. The
percentage of staining intensity obtained was taken to reflect the amount of mucus in
the cells analyzed. Data were presented as Mean ±S.E.
Cells immuno-stained with antibodies against H,K-ATPase were quantified
using the same software. Images were taken at 20x magnification. The corpus area
next to the fundus was selected for counting the cells per glands. The targeted labelled
cells were counted using the software and the number of glands were counted
manually. The periodic acid Schiff counterstaining was separated using color
deconvolution from the DAB staining. The data are represented the number of labelled
cells per glands. It was calculated by dividing the total of labelled cells by the total
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number of glands examined. Data was expressed as the mean number of cells per gland
± S.E.
2.4.6 Statistical Analysis
Student’s t-test was used for statistical analysis. The changes were compared
between control and dioxin-treated stomach tissues. The results were shown with error
bars indicating the mean ± standard errors (S.E). P-value < 0.05 was considered as
statistically significant.
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Chapter 3: Results
In this study, two types of 3D organoid models were generated. The first model
was from the mGS cell line which is representative for the gastric progenitor cells. The
second 3D organoid model was generated from freshly isolated neonatal mouse gastric
glands. These organoid models were characterized using immunohistochemistry,
electron microscopy and then utilized to study the role of AhR in gastric stem cell
biology.
3.1 Generation of mGS cell-derived organoids
This study suggests that the mGS cells were capable of forming 3D organoids
using hanging drop method for approximately 5-6 days prior to transferring them on
non-adherent surface (1.5% agarose-coated 96-well plates) for further growth.
Organoid growth was monitored using phase contrast microscope.
In hanging drop, the cells in the media initiate to migrate towards the inverted
tip of the media drop due to the gravitational force and then the cells clumped together
(Figure 9A). By day 3, the clumped cells proliferated and formed 3D organoids with a
proper circular 3D shape (Figure 9B). At day 6, organoids grew larger in size with
diameter of approximately 50 µm (Figure 9C).
At day 7, organoids were transferred on agarose coated 96-well plate (Figure
10A). Growth of the organoids were monitored every day. By day 17, organoids grew
in size approximately up to 100 µm (Figure 10B). After a month, the organoids were
healthy and maintained increasing in growth with diameter exceeding 300 μm (Figure
10C). Organoids can be maintained for months on agarose-coated culture plates.

55

Figure 9: Phase contrast images of mGS cells forming organoids by hanging drop. A)
mGS cells started clumping together at the bottom by day 1. B) At day 3, the cell
clumps proliferate and organize themselves into 3D organoid. C) Cells in the organoid
proliferated further and grew larger in size (50 µm). Bar=50µm.
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Figure 10: Phase contrast images of mGS cell-derived organoids on non-adherent
surface. A) A single 7 days old organoid (diameter 40 µm) was transferred to agarose
coated 96-well plate for proper media supply for growth and development. B) At day
17, organoid grew bigger in size indicating active cell proliferation (diameter 97 µm).
C) At day 27, the diameter of the organoid was enlarged to approximately 307 µm.
Bar represents the diameters of the organoid at different days.

57
To label the organoids and test for the viability of cells and whether any cells
have degenerated at three days, organoids were incubated with calcein (for live cells)
(Figure 11A). Calcein staining showed that the organoid was having proliferating cells
on the periphery leaving a gap at the center (Figure 11B, 11C). Calcein/propidium
iodide staining on 4 weeks old organoid indicated that live and healthy proliferating
cells were well-organized at the periphery surrounding dead or dying cells at the center
creating a cavity inside indicating continuous cell proliferation with accumulated dead
cells at the center of the organoids (Figure 11D).
Cell structure and viability in the organoid was further confirmed by electron
microscopic examination on a 4 weeks old organoid (Figure 12A). Cells on the
periphery had euchromatin, nucleus with large nucleus to cytoplasm ratio while cells
(Figure 12B) at center were condensed with dark nuclei (features of dead or dying
cells) (Figure 12C). Some of the cells in the periphery contains mucous granule-like
structures which could be a sign of early differentiation (Figure 12B).
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Figure 11: Phase contrast and confocal images of live and dead cells present in mGS
cell-derived organoids. A) Organoid at day 3 in hanging drop (diameter 27.4 µm). B)
Most of the cells in 3 days old organoid were live but more prominent at the periphery
detected by calcein staining (green). C) Higher magnification (40x) of calcein staining
of 3 days old organoid. D) 4 weeks old organoid stained with calcien (green) and PI
(red). Organoids showed dead cells at the center having live cells at the periphery
surrounding a cavity inside.
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Figure 12: Electron microscopic images of a 4 weeks old organoid derived from mGS
cells. A) A 4 weeks old organoid, having live and healthy cells at the periphery and
dying or dead cells at the center. B) Higher magnification of a live cell at the periphery.
Some of them have secretory granules that could be a sign of early differentiation
towards mucous cell lineage. C) A dying cell with a pale, condensed cytoplasm and
nucleus.

3.2 Generation of organoids from neonatal mouse gastric glands
In this study, the second model of 3D organoids were developed from freshly
isolated stomach glands of neonatal mice using matrigel method. These neonatal
glands are different from the adult mouse glands. Neonatal gastric glands are
comparatively shorter in length than adult mouse and usually populated mostly by
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immature progenitor cells with few mucous cells. Therefore, this study aimed to test
whether these immature glands have the ability to form 3D organoids and also to test
whether involvement of progenitor cells are involved in the development of these
organoids.
These 3D organoids were formed with a lumen at the center by day 1 and were
maintained up to day 10. The organoids grew larger in size and in some of them, there
were appearance of budding. Present study showed that progenitor cells from neonatal
gastric glands developed organoids within the matrigel (Figure 13).
3.2.1 Tracking BrdU-labelled proliferating cells in the organoids
Following BrdU injection, it gets incorporated into the DNA of the
proliferating cells during the s-phase of the cell cycle. BrdU immuno-staining of
neonatal mouse stomach showed that the glands were mostly made up of progenitor
proliferating cells throughout the glands (Figure 14A). To test whether organoids were
formed by the proliferating progenitor cells, BrdU-labelled cells in the organoids were
tracked on day 2, day 3 and day 4. Organoids were processed for paraffin sectioning
and BrdU labeling.
BrdU-labelled cells were detected at day 2 (Figure 14B), day 3 (Figure 14C)
and day 4 (Figure 14D) respectively. This identification of BrdU labeled cells at day
2 and day 3 in organoids indicated that progenitor cells were involved in the
development of gastric organoids. At day 4, the cells at the organoid center were also
found to be BrdU-labelled. This finding suggested that the lifespan of the proliferating
progenitor cells in the wall of organoids was less than four days (Figure 14D).
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3.2.2 Cellular characterization of primary organoids
3.2.2.1 Morphological analysis
Firstly, the organoids were stained with hematoxylin and PAS to detect any
mucus production in the organoids. PAS staining of the 4 days old organoid showed
the presence of some mucus in the lumen and at the brush border of the cells
characterizing their differentiation towards surface mucous cells (Figure 15A). To
further confirm differentiation, organoids were stained the with UEA-1 lectin specific
for surface mucous cells, and also with WGA lectin which labels membranes of gastric
epithelial cells. Both lectin stainings were positive (Figure 15B, 16B).
Cells of the gastric organoids were also studied to test their possible
differentiation by using immunohistochemistry. The organoids were firstly tested for
epithelial cell junction. E-cadherin was found to be expressed in the cells, confirming
that they were typical gastric epithelial cells connected to each other by cell junction
proteins (Figure 16A). Moreover, cells were tested for H,K-ATPase expression by
immunohistochemistry. Some cells showed little expression of H,K-ATPase,
indicating that some progenitor cells have partially differentiated into pre-parietal cells
which may later differentiate into parietal cells (Figure 16C). However, cells were
tested negative for markers of other differentiated cell types including chromogranin
A specific for endocrine cells (Figure 16D), pepsinogen specific for zymogenic cells
(Figure 16E), and GS lectin for neck cells showed moderate staining in some cells
(Figure 16F).
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3.2.2.2 Expression analysis of gastric epithelial-specific genes during organoid
development
Organoids at day 2, day 4 and day 10 were collected for RT-qPCR analysis, to
study expression patterns of genes specific for different cell lineages in the gastric
glands throughout their development process. Data revealed that at day 2, organoids
expressed genes specific for surface mucous cells (Muc5AC, TFF1). However,
expressions of Muc5AC and TFF1 showed gradual decrease at day 4 and highly
downregulated at day 10. This may imply that some surface mucous cells were
generated in the organoids from the stem/progenitor cells and later were degenerated
(Figure 17). This could be supported by the fact that these cells have a short lifespan.
Moreover, at day 2, MUC6, specific for neck mucous cells did not show any
expression, while at day 4, it is upregulated and highly upregulated at day 10. TFF2
(also specific for neck mucous cells) showed very low level of expression at day 2
which highly upregulated at day 4 and day 10. These findings indicated that cells at
day 4 and 10 started differentiating towards mucous neck cells (Figure 17).
Genes expressed in parietal cells (H,K-ATPase) and endocrine cells (chromogranin A)
were also detected at day 2, but were highly downregulated at day 4 and day 10, which
indicated that some H,K-ATPase and chromogranin A producing cells were also
present along with the progenitor cells during early stages of organoid development
(Figure 17).
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Figure 13: Phase contrast images of organoids from neonatal gastric glands. A short
neonatal gland with few cells seeded in matrigel at day 0. By day 1, organoid was
formed from the neonatal glands with a prominent outer layer of cells having lumen at
the center. Cells of the organoid proliferated, and the organoid grew in size, some cells
started to bud outwards. Figure showing organoid upto day 6. Organoids were
maintained up to day 10. Bar=200 µm.
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Figure 14: Tracking BrdU-labelled cells in the organoids. A) BrdU-labelled cells,
scattered throughout the gland of the neonatal mouse stomach (yellow arrows pointing
on BrdU-labelled cells), indicating that most of the cells are proliferating. Organoids
were grown from BrdU injected neonatal gastric glands, which showed positive BrdU
staining (yellow arrows) at B) day 2, C) day 3 and D) day 4, respectively, indicating
the involvement of proliferating progenitor cells in the organoid development. At day
4, the dead cells at the center also were BrdU positive which suggested that the lifespan
of the proliferating cells was approximately 4 days. Bar=100 µm.
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Figure 15: PAS staining and lectin histochemistry images of gastric organoids. A)
Periodic acid Schiff staining on a 4 days old organoid showed that it contained mucus
in the lumen and at the brush border (white arrows) which detected surface mucous
cells. Hematoxylin stained the nucleus (purple). B) Organoids showed positive
staining for WGA lectin (green) specific for cell membrane and UEA-1 lectin (red) for
surface mucus cells. Most of the UEA-1 staining was observed at the center, an
indication of the presence of mucus in the lumen. Bar=50 µm.

66

Figure 16: Immunohistochemical and lectin histochemical analysis of gastric
organoids. A) E-cadherin, a cell junction marker, specific for gastric epithelial cells
were detected between the junctions of the cells (white arrows). B) WGA specific for
cell membrane showed positive staining. C) Some cells showed little expression of
H,K-ATPase (white arrows), indicating that some progenitor cells were H,K-ATPase
positive pre-parietal cells. Furthermore, D) chromogranin A for endocrine cells and E)
pepsinogen for zymogenic cells did not show any expression. F) GSII lectin specific
for neck cells showed moderate staining (white arrows) in some cells. PI was used as
a nuclear stain (red) for E-cadherin, H,K-ATPase, WGA and GSII staining. Bar=50
µm.
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Figure 17: RT-qPCR analysis of gastric epithelial cell lineage specific genes at
different stages of gastric organoid development (days 2, 4 and 10). At day 2,
organoids expressed genes of surface mucous cells (Muc5AC, TFF1), whereas, at day
4 and day 10, Muc5AC and TFF1 expressions were gradually downregulated. Genes
specific for neck mucous cells (MUC6 and TFF2) showed no or low expression levels
at day 2 and upregulated at day 4. Genes expressed in parietal cells (H,K-ATPase) and
endocrine cells (chromogranin A) were detected at day 2, but were downregulated at
day 4 and day 10.
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3.3 Use of organoid models to study role of AhR activation on stem cells
Before using gastric organoids to investigate the effects of dioxin activated
AhR on gastric stem cells, it was necessary to define the expression of AhR in gastric
epithelial cells and tissues.
3.3.1 AhR expression in mGS cells
To test whether AhR is expressed in stem cells, it was thought initially to try
the AhR antibodies on mGS cells. Immunofluorescence staining showed that AhR was
expressed in mGS cells. The staining was mostly located in nucleus with less intense
staining in cytoplasm (Figure 18). These findings justified the needs to characterize
AhR expression in stomach tissue.
3.3.2 AhR expression in neonatal mouse stomach
Neonatal stomach glands are not compartmentalized. They are short and
mostly populated by proliferating progenitor cells along with few poorly differentiated
surface mucous cells, neck mucous cells and parietal cells. They have no zymogenic
cells, as these glands are not fully matured yet.
Immunohistochemistry revealed that AhR expression was detected all
throughout the glands from the surface near to the lumen to the bottom, mostly nuclear
with few cytoplasmic expressions (Figure 19A, Figure 19B). This indicated that AhR
was expressed in progenitor cells in its activated form, therefore it may have a role in
the proliferation and on differentiation of the progenitor cells.
Moreover, some neonatal mice were injected with BrdU and the localization
of pattern of BrdU-labelled proliferating cells was compared with those expressing
AhR. Immunohistochemistry revealed that BrdU-labelled cells were scattered
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throughout the neonatal glands from surface to the bottom towards the muscularis
mucosa (Figure 20A). When compared with location of the AhR-expressing cells, it
was found to be very similar to the location of BrdU-labelled cells (Figure 20B).
However, as BrdU only labels the cells at the S-phase of the cell cycle and injection
was for two hrs only, there was a possibility that not all the progenitor proliferating
cells showed BrdU labeling but expressed AhR. This could explain why AhR-labelled
cells appeared more numerous than BrdU-labelled cells.

Figure 18: AhR expression in mGS cells. Immunofluorescence staining confirmed that
AhR was expressed in mGS cells (green), both in nucleus and in cytoplasm. Bar=100
µm.
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Figure 19: AhR expression in neonatal gastric glands. A) AhR expression was detected
scattered throughout the glands from the surface to the bottom, mostly nuclear with
few cytoplasmic expressions. Bar=50 µm. B) higher magnification (40x) image of
nuclear AhR expression. Bar=20 µm.

Figure 20: Comparison between cellular localization of BrdU and AhR expressions in
two adjacent tissue sections obtained from neonatal stomach. A) BrdU-labelled
proliferating cells appear scattered throughout the neonatal glands (arrows). B) AhR
expression was also detected distributed all over the glands and in some places both
the stains localized at similar cellular nuclear locations (arrows). Different colored
arrows represented different locations where both BrdU and AhR were expressed.
Bar=20 µm.
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3.3.3 AhR expression in gastric organoids
This study also showed that AhR was expressed in gastric organoids using
immunohistochemistry. Both nuclear and cytoplasmic AhR were detected in the
gastric organoids (Figure 21).
3.3.4 Effects of dioxin treatment on primary gastric organoids
In this study, gastric organoids were used to test the effects of dioxin mediated
AhR activation on gastric stem cell proliferation and differentiation which may later
hint about its role in gastric stem cell biology and cancer development. For this
purpose, considering the source (neonatal gastric glands), primary gastric organoids
were chosen because these organoids showed differentiation and mimicked in vivo
conditions of epithelial progenitors.

Figure 21: AhR expression in gastric organoids. Both nuclear and cytoplasmic AhR
(green) were detected in some cells of the 3D primary organoids (white arrows). PI
stained the nucleus (red). Bar=50 µm.
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Primary organoids were treated with dioxin (0.1 nM and 1 nM) when the
organoids were 2 days old. Organoid growth was monitored using phase contrast
microscope. In control organoids, cells were healthy, organoids grew larger by second
day (day 0 of dioxin treatment) and started accumulating dead cells by forth day (day
2 of treatment) (Figure 22A, 22B, 22C). With dioxin treatment (0.1 nM and 1 nM),
organoid growth was morphologically similar to control at day 2 (treatment day 0), as
no change was expected right after the treatment (Figure 22D, Figure 22G). At day 3
(treatment day 1) and day 4 (treatment day 2), organoids did not show any
morphological changes in both the dioxin treated organoids (Figure 22E, 22H, 22F,
22I).

Figure 22: Phase contrast images of dioxin-treated gastric organoids at different
treatment days. A) In control organoids, cells were healthy, organoids grew larger by
second and B) third day (treatment day 0 and 1) and accumulated few dead cells by C)
forth day (day 2 of treatment). At Day 2 (treatment day 0), in both 0.1 nM and 1nM,
no change was expected (D, G). At Day 3 (treatment day 1) and Day 4 (treatment day
2), organoid growth was morphologically similar to control for both the dioxin
concentration (E, F, H, I). Bar=100 µm.
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4 days old organoids after two days of dioxin treatment were collected for
analysis. Organoids treated with higher concentration of dioxin were selected for
histological analysis.
Firstly, cell viability tests for both control and treated organoids showed calcein
staining in cytoplasm of live cells and propidium iodide in nuclei of dead cells. In
control organoid, almost all the cells were alive with few dead cells (Figure 23A). In
the treated organoids, cells were alive and healthy at the periphery but with more dead
cells than in control (Figure 23B). This finding indicated that dioxin activated AhR
was possibly increasing the cell proliferation rate in the organoids, so the cells were
dividing faster and the dead cells were accumulating at the center more than the normal
ones.

Figure 23: Celcein/PI staining images of dioxin-treated organoids. A) Control
organoid had mostly live, healthy cells (green) and very few dead cells (red) at the
center. B) Treated organoids had live cells (green) mostly at the periphery and more
dead cells (red) at the center than to the untreated ones. Bar=100 µm.
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Moreover, dioxin-treated organoids were incubated with UEA-1 lectin to test
the role of dioxin activated AhR on surface mucous cell differentiation. In control
organoid, UEA-1 staining detected the mucus layer in apical cytoplasm of cells and
some positive staining were also observed at the center (Figure 24A). In contrast,
UEA-1 staining was more intense in the dioxin-treated organoids and most of the dead
cells at the center also found to be UEA-1-labelled (Figure 24B). This can be an
indication that AhR increases the mucous secretion and cell differentiation towards the
surface mucous cells.

Figure 24: Lectin histochemical images of dioxin-treated organoids. A) UEA-1 lectin
stained the mucus brush border (red) in the control organoid with some moderate
staining at the center. B) Dioxin-treated organoids showed more intense UEA-1
staining compared to the control with a greater number of dead cells in the lumen.
Most of the dead cells at the center also found to be UEA-1-labelled. Bar=50 µm.

Furthermore, dioxin treated organoids were also tested for any effects on
differentiation towards H,K-ATPase expressing cells using immunohistochemistry. In
control organoids, few specific areas in the cell cytoplasm were detected for H,KATPase (Figure 25A). Compared to the control, dioxin-treated organoids showed more
and intense staining of H,K-ATPase (Figure 25B). This could be an indication that
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AhR may have a role in enhancing cell differentiation towards H,K-ATPase producing
cells.
3.3.5 Effects of dioxin treatment on gene expression patterns of primary gastric
organoids
Following morphological analysis, RT-qPCR was performed with the total
RNA from dioxin-treated (0.1 nM and 1 nM) and un-treated gastric organoids, to
analyze the gene expression patterns in dioxin-treated organoids. Organoids at day 2
were treated with dioxin, (0.1 nM and 1 nM) and collected at day 4 for RT-qPCR
analysis.
mRNA for CYP1A1 (a typical AhR target gene) was chosen as a functional
marker of AhR activation. CYP1A1 mRNA was detected with specific primers in the
total RNA prepared from the dioxin treated organoids with and was not detected in the
control organoids. CYP1A1 expression is increased with the increasing concentration
of dioxin. These results suggested that the AhR was functional and activated by dioxin
(Figure 26A).
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Figure 25: H,K-ATPase staining images of dioxin-treated organoids. A) Control
organoids showed one or two spots (white arrows) in the cytoplasm where H,KATPase expression was detected. B) Dioxin-treated organoids showed more and
intense staining (white arrows) of H,K-ATPase even at the center. PI stained the
nucleus (red). Bar=50 µm.

Expression of AhR was also measured in the treated organoids. There was a
decrease in AhR expression level with increased concentration of dioxin treatment, but
the change was not statistically significant (Figure 26B).
Firstly, using specific primers RT-qPCR was done to reveal the mRNA
expression levels of gastric-specific genes (Muc5AC and TFF1 specific for surface
mucous cells, MUC6 and TFF2 for mucous neck cells and H,K-ATPase specific for
parietal cells) in dioxin-treated and control gastric organoids to test whether AhR has
any role on cell differentiation. Muc5AC and TFF1 showed higher expression in
dioxin-treated organoids compared to the control organoids. Muc5AC showed higher
expression in 0.1 nM concentration of dioxin and TFF1 expression was higher in 1 nM
dioxin treatment. This data altogether supported the result from lectin-histochemical
analysis of the treated organoids that activated AhR increased cell differentiation
towards mucous cells, but the change was not statistically significant (Figure 26B).
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In addition, mRNA expression of MUC6 (specific for mucous neck cells) was
significantly reduced in both the concentration of dioxin treatment compared to control
organoids, while TFF2 (also specific for mucous neck cells) expression was slightly
decreased in 0.1 nM and increased in 1 nM treatment. Data for TFF2 was not
statistically significant. These data indicated that activated AhR decreased cell
differentiation towards mucous neck cells (Figure 26B).
Additionally, H,K-ATPase showed higher expression in the treated organoids
than the control ones, which corresponded to the data from immunostaining analysis.
Data was analyzed and the change did not show statistical significance. Chromogranin
A expression was also studied, which did not show any significant change in the
treated organoids when compared to the control (Figure 26B).
Next, primers specific for stem cell markers (Lrig1, RUNX1, Troy, Oct-4 and
CD 44) were used to study role of AhR activation on stem cell regulation (Figure 26B).
Lrig1 expressions in organoids were reduced in both the concentration of
dioxin treatment with significant reduction in 0.1nM concentration. Dioxin treatment
also showed significant reduction in CD44 expression for both the treatment
conditions. These findings indicated that AhR activation decreased proliferation of
Lrig1 and CD44+ stem cells and increased cellular differentiation.
RUNX1 expression did not show any change in 0.1 nM, but highly expressed
in 1 nM treatment, though data was not statistically significant. Furthermore, the
expression of Troy was also slightly increased in both the treated organoids, however
the change was not significant. Thus, AhR activation did not show any significant
change in RUNX1+ and Troy+ stem cells.
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Lastly, Dioxin-activated AhR showed increase in Oct-4 expression (marker for
self-renewal of stem cells) in both the dioxin concentrations, with significant increase
in 0.1 nM treatment, which indicated that AhR activation enhanced self- renewal
process in the progenitor cells present in the gastric organoids.
3.4 Effects of dioxin treatment on gastric mucosa
AhR is generally found to be expressed in many organs and only upon
activation by specific ligands it is functionable. Dioxin was a commonly used ligand
by researchers for AhR activation for research purposes. It activates AhR and helps in
transcription of metabolic enzymes depending on specific functions.
This study also tested effects of AhR activation in vivo. To activate AhR, mice
were injected with dioxin (50 um/kg) for 3 consecutive days and one day later
sacrificed. Stomach tissues from control (n=3) and dioxin-treated (n=3) were then
analyzed by lectin histochemistry and immunohistochemistry. Tissues were embedded
as 3 individual pairs each having one control and one treated, positioned side by side
to each other.
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Figure 26: Effects of dioxin-activated AhR on mRNA expressions of gastric cell
specific markers and gastric stem cell markers. A) Increase in CYP1A1 expression in
the dioxin-treated organoids confirmed AhR activation. B) Expression of AhR was
reduced in treated organoids. Surface mucous cell speficific-Muc5AC and TFF1
showed higher expression in 0.1 nM and 1 nM dioxin treatment. MUC6 (specific for
mucous neck cells) expression was significantly reduced in both the concentration of
dioxin-treated organoids and TFF2 (also specific for mucous neck cells) expression
decreased in 0.1 nM and increased in 1 nM treatment. Furthermore, H,K-ATPase
expression was higher in the treated organoids than the control ones. Chromogranin A
expression did not show any significant change in the treated organoids. Stem cell
marker, Lrig1 expression was downregulated in both treatments with significant
reduction in 0.1 nM. Moreover, CD44 expression (stem cell marker) was also
significantly downregulated in both the dioxin treatment conditions and RUNX1 (stem
cell marker) expression didn’t show any change in 0.1 nM but upregulated in 1 nM
treatment. Expression of Troy (stem cell marker) was also upregulated in dioxintreated organoids. Lastly, Oct-4 expression (marker for stem cell self-renewal) was
increased in both the concentrations of dioxin treatment, with significant increase in
0.1 nM treatment. Data were biological replicates of independent experiments. Bars
represent the SEM. The asterisks indicate the significance of change in gene
expression between the control and dioxin-treated organoids, *p<0.05, **p< 0.01,
***p < 0.001.
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3.4.1 Characterization of AhR expression in stomach tissues
To test effects of dioxin activated AhR on stomach, it is important to test the
expression of this receptor in stomach tissues. In this study, AhR expression was
detected using immunohistochemistry in adult mice and rat stomach tissues.
3.4.1.1 AhR expression in adult mouse stomach
AhR expression was studied to test whether it is expressed in normal adult
gastric glands. Stomach glands in mice are tubular and consist mostly of matured
differentiated cells unlike the neonatal glands.
In the corpus glands, AhR was found to be expressed in nucleus, mostly in the
middle of the glands with moderate cytoplasmic expressions (Figure 27A, 27B). This
concluded that AhR was not only limited to progenitor cells but also expressed in
differentiated cells, which was an indication that it may have a role in stem cell
differentiation process.
3.4.1.2 AhR expression in rat stomach
In addition, this study also tested AhR expression levels in rat stomach (BrdU
injected). BrdU-labelled cells were mostly located at the isthmus region (Figure 28A).
Expression of AhR in rat stomach glands is nearly similar to expression in adult mouse
glands and mostly expressed in the neck area near the base, localized both in cytoplasm
and nucleus and few localized in the isthmus region (Figure 28B, 28C).
3.4.2 Effects of dioxin activated AhR in vivo
The last objective of this study was to test the effects of dioxin activated AhR
in vivo. 21 days old mice were given daily injections of dioxin for three consecutive
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days and sacrificed on the fourth day. The stomachs were then studied using
immunohistochemistry and lectin histochemistry.
3.4.2.1 Detection of activated AhR expression in mouse liver
Firstly, liver tissue was examined to detect activated nuclear AhR as a positive
control because it was well established that the liver is a target organ for dioxin. Both
the control and dioxin-treated liver were processed together, embedded in same block,
mounted on same slide and exposed to immunolabelling simultaneously.
The liver is mostly made up of hepatocytes with round nucleus with one or two
nucleoli. Immunohistochemistry confirmed that in control liver, AhR expression was
visible in both cytoplasm and nucleus but the intensity was weak (Figure 29A). In the
treated liver, AhR-labelled nuclei were more in number and intensity was also higher
than in the control tissue (Figure 29B). This finding was an indication that AhR was
activated by dioxin treatment.
3.4.2.2 Detection of activated AhR expression in mouse stomach
AhR activation was tested in the stomach tissues using immunohistochemistry.
Data in control stomach showed that, AhR expression was localized in both cytoplasm
and nucleus of epithelial cells mostly in the middle region of the gland (Figure 30A).
In the treated stomach, a similar pattern was observed but nuclear AhR expression was
detected with higher intensity and more in numbers than the control tissue (Figure
30B), indicating that AhR was activated in the stomach by dioxin treatment. Data was
supported by RT-qPCR showing significant increase in CyP1A1 gene expression
(Figure 30C).

82

Figure 27: AhR expression in adult mouse stomach. A) Immunohistochemistry study
showed that nuclear AhR expression was expressed in corpus glands mostly in the area
above the base of the glands. Few cytoplasmic AhR was also detected. B) Higher
magnification image of nuclear AhR expression (red arrows pointing towards nuclear
AhR stain).
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Figure 28: Immuno-labelling images of BrdU and AhR expression in rat stomach. A)
BrdU-labelled proliferating cells (brown) were detected at the isthmus region.
Bar=100 µm. B) Cytoplasmic and nuclear AhR (Brown) was found in the neck area
near the base, few cells with AhR expression were also detected near the isthmus
region. Bar=100 µm. C) higher magnification image of AhR expression. Bar=20 µm.
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Figure 29: Dioxin-treated AhR activation in mouse liver. A) In control liver, both
cytoplasmic and nuclear AhR expression (pointed with arrows) were visible but the
intensity was less. B) In the treated liver, the number of nuclear AhR (pointed with
arrows) was more and the intensity was also higher than the control tissue. Bar=100
µm.

Figure 30: Dioxin-treated AhR activation in mouse stomach. A) Control stomach
tissues showing AhR expression in cytoplasm and nucleus (arrows) in the middle
region of the gland. B) In the treated stomach, highly intense nuclear AhR stain
(arrows) was detected in the similar area compared to the control tissue (arrows).C)
CyP1A1 expression was significantly increased. Bar=100 µm.
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3.4.2.3 Characterization of mucous cells in control and dioxin treated stomach
Lectin histochemistry was used to study the effects of AhR on surface mucous
cells and neck cells. UEA-1 lectin was used for surface mucous cells, and GSII lectin
was used for neck cells. In control stomach, UEA-1 stained the cells at the epithelial
lining and the luminal surface (Figure 31A). GSII stained epithelial cells in the middle
of the glands which correspond to the neck cells at the neck region (Figure 31C). The
treated stomach showed a reduction in the intensity of UEA-1 staining of surface
mucus cells (Figure 31B). The GSII labeling in dioxin-treated stomach also showed a
decrease in the staining intensity (Figure 31D). To quantify the data, statistical analysis
was done for the staining intensities to compare between the control and treated
stomachs (Figure 31E, 31F). Therefore, with the recent data it was not possible to
detect significant effects for AhR on surface mucous cells and neck cells.
3.4.2.4 Characterization of parietal cells in control and dioxin treated stomach
Immunohistochemistry was used to examine whether dioxin activated AhR has
any effects on the parietal cells using antibody against H,K-ATPase. Immunostaining
intensity of parietal cells was analyzed. In control stomach, H,K-ATPase parietal cells
were detected throughout the gland from pit region (near to lumen) to base (near to
muscle layer) (Figure 32A). There was a reduction in the labelling intensity of parietal
cells exposed to dioxin (Figure 32B). The data was statistically analyzed, which
showed that AhR may not have significant but moderate effects on parietal cells
(Figure 32C).
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Figure 31: Effects of dioxin treatment on mucous cells. A), C) In the control stomach,
rhodamine-conjugated UEA-1 lectin detected surface mucous cells (red), and
fluorescein isothiocyanate-conjugated GSII lectin detected neck mucous cells (green)
in the gastric mucosa. B), D) In the treated stomach, there was a reduction in the
intensity of UEA-1 staining and the GSII staining respectively. The graphs E and F
showed the percentages of labelling intensity of UEA-1 and GSII in control and treated
stomach respectively. Data was presented as mean ± SEM. Bar=50 μm.
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Figure 32: Effects of dioxin treatment on parietal cells. A) In control stomach, H,KATPase+ parietal cells (brown color) were detected throughout the gland from pit
region to base. Tissues were counterstained with PAS. B) In the treated stomach, the
number of parietal cells was similar to control, but the labelling intensity showed
moderate reduction. Bars=100 µm. C) The graph showed the staining intensity
differences between H,K-ATPase+ cells in control and treated stomachs. Data are
presented as mean ± SEM.
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Chapter 4: Discussion
In this study, two novel types of organoid models were developed: one from
the mGS cells and the other from neonatal stomach glands. These models will be an
addition to the available models used by scientists previously to study gastric stem
cells and their role in the differentiation of gastric epithelial cells and gastric cancer
development.
Following their characterization, gastric organoids were used to study effects
of dioxin activated AhR on gastric stem cells, which will also open a door in research
on gastric cancer development as gastric stem cells and AhR are believed to be
involved in carcinogenesis. This idea was based on some previous studies
demonstrating upregulation of AhR in cancer tissues and augmentation of stem cells
during cancer development. It is still questionable how the factors are involved and
whether the effects are cancer driven or inhibitory.
4.1 Gastric organoids from mGS cells
The mGS cells are cloned immortal cells developed from a mouse model with
amplified progenitor cells. These cells have some important morphological and
molecular characteristic features similar to gastric progenitor cells. They have large
nucleus-to-cytoplasm ratio, nucleus with reticulated nucleoli and abundant
euchromatin, cytoplasm containing many free ribosomes, a few small cisternae rough
endoplasmic reticulum, scanty mitochondria, and undeveloped Golgi apparatus.
Furthermore, these cells express some stem cell markers such as Notch3, Oct-4, CD44
and DCLK1 (Al-Marzoqee et al., 2012; Giannakis et al., 2008). Thus, these cells can
be a good alternative source to study stem cells. Previously, these cells were
characterized in two-dimensional culture. However, recently, demands on 3D cell
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culture models for stem cell research is increasing because of its high efficiency
towards mimicking in vivo conditions and for possible use in tissue engineering.
Recently, a study on the mGS cells were cultured on 3D electrospun microfibrous
polycaprolactone scaffolds and maintained for upto 9 days. This culture conditions
supported their differentiation into surface mucous cells (Pulikkot et al., 2014). In the
present study, the mGS cells were used to develop organoids which were maintained
for upto 6 months.
In this study, two protocols were used to develop organoids from mGS cells.
First one is hanging drop method. mGS cells were seeded in hanging drops of RPMI
media and cells aggregated towards the bottom of the media drop and formed a small
mass of cells. Cells were then transferred on agarose-coated 96-well plates for further
growth. This technique is known as force floating technique. Within a month, the
organoids grew larger in size with diameter of 400 μm. Organoids were maintained on
agarose for upto four months and they grew even larger. Furthermore, cell viability
tests and electron microscopic analysis on mGS cell-derived organoids indicated that
the organoids were structured into live, healthy proliferating cells in the periphery with
dead or degenerating cells at the center. Some of the cells on the periphery contained
mucous granule-like structures, indicating sign of early differentiation. mGS cells were
also capable of forming 3D organoids while seeded in matrigel. Therefore, using these
3D organoids could be another beneficial in vitro model for studying gastric stem cells.
They are reproducible and made of cells easily accessible. They develop in
conventional media without a need for growth factors.
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4.2 Gastric organoids from neonatal mouse gastric glands
The second organoid model was developed from freshly isolated stomach
glands of 4-day old neonatal mice using matrigel technique. Neonatal stomach glands
are mostly composed of proliferating progenitor cells with few poorly differentiated
surface mucous cells, neck mucous cells and parietal cells and they lack zymogenic
cells (Karam & Leblond 1995).
The first 3D primary gastrointestinal organoid models were established from
intestinal glands (Sato & Clevers, 2013) using the matrigel technique along with a mix
of growth factors including R-spondin-1, noggin, and FGF-10. Using a similar
protocol, stomach organoids were developed from corpus glands of the gastric mucosa
(Barker et al., 2010; Stange et al., 2013). These previously established models of
organoids were reported using only adult mouse stomach. The present study was
designed to develop gastric organoid models from “neonatal” glands as these glands
are mostly made up of immature progenitor cells. This 3D model will be helpful for
future studies on gastric stem cell dynamics and differentiation pathways based on the
fact that neonatal gastric glands mostly consist of progenitor cells.
Immature glands were isolated from neonatal mouse and seeded in matrigel in
the presence of growth factors important for stem cell proliferation and differentiation
during stomach development. Cells from glands organized themselves into spherical
organoids with a lumen at the center by day one and they were maintained up to day
10. Cell viability tests on these organoids showed that almost all the cells in the
organoids were live with only few dead cells at the center.
To demonstrate that organoids originate mostly from stem/progenitor cells,
some of the organoids were grown from BrdU-injected neonatal mice. This could help
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to track the proliferating progenitor cells during the organoid development. Immunohistochemistry revealed that organoids were having BrdU-labelled cells even up to day
4, which was an indication of continuous proliferation of progenitor cells while
progressing towards differentiation. Some of the BrdU labelled cells were also present
at the center in the lumen of the organoids, which indicates the short lifespan of
progenitor cells as previously shown in the mouse stomach (Karam, 1993). These
findings provide an evidence for the generation of the organoids from progenitor stem
cells as suggested.by previous studies. (Barker et al., 2010)
Furthermore, UEA-1 lectin histochemistry confirmed the presence of surface
mucous cells and H,K-ATPase synthesizing cells were also detected using
immunohistochemistry in 3D primary organoids. This data was supported by RTqPCR analysis on organoids at day 2. 2-day old organoids showed mRNA expressions
of surface mucous cell specific Muc5AC and TFF1 as well as parietal cell specific
H,K-ATPase, which is an indication that stem cells differentiated to surface mucous
cells and H,K-ATPase producing cells by day 2. The expressions of Muc5AC and
TFF1 were comparatively higher than that of day 8 and day 10. This data suggested
that because of the short lifespan of surface mucous cells some cells that are generated
at day 2 started to degenerate during the later days. There is also a possibility that some
cells were probably there from day 0 in the glands while they were extracted, but it is
very unlikely that the differentiated cells will survive in the culture for two days. H,KATPase and CgA expressions were low at day 4 and 10. This could be an indication
that cells were initially differentiated towards H,K-ATPase producing cells and
endocrine cells, but the culture conditions were not suitable for the survival for these
cells. Another reason for these findings can be supported by the idea proposed by some
previous studies that some differentiated cells were already there from day 0, along
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with the proliferating progenitor cells (Burkitt, Duckworth, Williams, & Pritchard,
2017), though it is not expected that the differentiated cells from the glands will
survive.
Organoids at day 4 and day 10 showed expressions of MUC6 and TFF2
(specific for neck mucous cells), which was undetectable and low respectively at day
2. Thus, the progenitor stem cells in the organoids were also differentiated towards the
mucous neck cells. Cells in the organoids were also tested for pepsinogen expression,
which was very low or undetectable.
These organoid models can be used to assess detailed early differentiation
steps towards mucous cells and parietal cells.
4.3 Effects of AhR activation on gastric stem cells and gastric cancer in vivo and
in vitro
In the present study, the effects of dioxin-activated AhR on gastric stem cells
were tested using organoids and in vivo using mouse. As a first step, AhR expression
was tested in gastric epithelial cells, tissues and organoids.
Immunohistochemical analysis revealed that AhR was found to be expressed
in the mGS cells, mouse and rat stomach tissues and also in gastric organoids. Both
nulear and cytoplasmic AhR were detected.
AhR is a well-known factor for its role in pathogenesis of cancer development.
Recently, researchers also tested variations in the expression level of cytoplasmic and
activated nuclear AhR in the human gastric cancer tissues. One of such study showed
that AhR expression is inhibited in the presence of H. pylori in H. pylori-related gastric
cancer (Zhu et al., 2018). Therefore, this study also tested the expression levels of AhR
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in human tissues of different conditions starting from normal to gastritis to tumor
tissues respectively. In this study, gastric mucosal tissues were collected from the
pyloric region of patients at Tawam Hospital undergoing endoscopy (n=89) for the
examination of recurrent upper gastrointestinal symptoms, or gastrectomy (n=3) for
adenocarcinoma. All patients gave written informed consent prior to the study.
Following the endoscopic or surgical procedures, biopsies or cancer tissues (taken
from 3 areas: tumor, tumor edge and from the safe margin) were processed for
immunohistochemistry (Al-Marzoqee et al., 2012). For the AhR expression study, 3
sets of tissues were chosen from 3 different patients for each condition (normal,
gastritis, tumor, safe margin).
Immunohistochemistry revealed that with the increasing progression of gastric
cancer, the level of AhR expression increased. In normal tissues, the AhR expression
was very low or undetectable (Figure 33A), while in gastritis tissues mild expression
of nuclear AhR was detected in the pit area of the glands (Figure 33B). In the safe
margin region, which is most likely the nearby area to the tumor, AhR expression (both
nuclear and cytoplasmic) was increased (Figure 33C). Moreover, the staining intensity
of nuclear AhR was higher in tumor tissues and localized in both basal and epical
surface (Figure 33D). These data supported the previous evidences on the role of AhR
expression and its involvement in gastric cancer development. These data can also be
co-related with the results from a previous study on the same tissues that showed
upregulation of self-renewal gene Oct-4 in the similar areas during the progression of
the cancer (Al-Marzoqee et al., 2012), indicating that AhR plays a role in the stem cell
self-renewal.
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Figure 33: AhR expression in human tissues (normal, gastritis and tumor). A) AhR
expression was very low or undetectable in the normal tissues. B) In gastritis tissues,
mild expression of nuclear AhR was observed in the pit area of the glands (arrows).
C) In the safe margin region, nuclear and cytoplasmic AhR expression were detected
(arrows). D) Compared to other regions, tumor area showed highly intense expression
of nuclear AhR (arrows). Bar=100 µm.

4.3.1 Effects of AhR activation on gastric organoids
AhR mRNA is normally expressed in many human tissues with high
expressions in liver, pancreas, lungs, spleen, placenta and relatively low in brain,
skeletal muscles and heart (Jiang et al., 2010; Spence et al., 2011). Both protein and
mRNA AhR expressions have also been reported in placentas of mouse and rabbits. as
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well as in fetal tissues (high expressions in lungs, liver, kidneys, pancreas, testicles,
esophagus, thymus glands, retinas, and epithelial cells and comparatively low levels
in the heart, brain, choroids, thoracic aorta, and sclera) (Jiang et al., 2010). The
distribution of intracellular AhR expressions changes significantly with age. AhR has
been studied mainly in the environmental toxicological field because of its role in
mediating xenobiotic metabolism and environmental responses (Yi et al., 2018).
Recently, studies also started investigating the involvement of activated AhR
in maintenance of stem cell homeostasis, which was first suggested by Singh et al.,
(2019). Their study showed that, the AhR expression was vital for the proper
maintenance of quiescence in HSCs and AhR down-regulation was needed for
“escape” from quiescence state and subsequent proliferation of HSCs. Another study
on skin stem cells proposed that activated AhR altered stem cell proliferation and
differentiation towards the epidermal pathway at the expense of hair follicle and
sebaceous gland cells (Arnold & Watt, 2001; Panteleyev & Bickers, 2006). Adding to
it, previous studies have also revealed that AhR was an important regulatory factor in
neural development, indicated by expression of both AhR and ARNT genes in the
embryonic neuroepithelium as well as neural stem cells. Studies on AhR-KO mice
proposed that AhR was important for development and/or maintenance of this
neuronal population. Together, these studies supported the positive contribution of
AhR activation in neurogenesis through regulation of neural stem cells and neuronal
precursor cells (Abbott et al., 1995; Abbott & Probst, 1995; Collins et al., 2008;
Williamson et al., 2005).
Using different mouse models, scientists also suggested that AhR play a
significant role in intestinal homeostasis. The study discovered that AhR influenced
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the regeneration of intestinal epithelial cells (IECs) upon injury and removal of AhR
in IECs resulted in uncontrollable cell proliferation and reduced differentiation.
Whereas, ligand-bound activated AhR restored ISCs homeostasis maintaining the
niche and was also able to block tumorigenesis (Metidji et al., 2018). These findings
supported the need for studying role of AhR in stomach stem cell homeostasis, as
stomach and intestine are inter-connected through common developmental pathways
and there is lack of information on its role on gastric stem cell regulation and tissue
development. Therefore, this study focused on studying the role of AhR on gastric
stem cells using organoids.
Two days incubation of gastric organoids with dioxin induced AhR activation
as indicated by upregulation of its target gene, cytochrome p450. This was associated
with upregulation of Muc5AC and TFF1 (specific for surface mucous cells) and
parietal cell specific-H,K-ATPase, indicated by lectin histochemistry and PCR.
Following, dioxin treatment significantly decreased the cell differentiation towards
neck mucous cells, indicated by significant down regulation of MUC6 mRNA
expressions. Therefore, dioxin-activated AhR plays an important role in differentiation
directions of progenitor proliferating cells towards mucous neck cells.
This study tested role of dioxin-activated AhR on gastric stem cells using RTqPCR. mRNA expressions of various stem cell markers (Lrig1, RUNX1, Troy, Oct-4
and CD44) were examined in dioxin-treated organoids. Dioxin treatment significantly
reduced the Lrig1 expression, which can be an indication that dioxin treatment reduced
the proliferation of Lrig1+ cells. Moreover, RUNX1 and Troy expressions were
upregulated in the treated organoids. Though the change was not statistically
significant.

97
Moreover, present data showed that AhR activation enhanced self-renewal
process in the progenitor cells indicated by the significant upregulation of the Oct-4
gene in the gastric organoids. This data was supported by information from previous
studies demonstrating that Oct-4 is involved in the self-renewal of undifferentiated
embryonic stem cells by investigating the target genes using genomic scale location
analysis (chromatin immunoprecipitation coupled with DNA microarrays) (Laurie et
al., 2005). Thus, in the present study, Oct-4 was used as a marker for self-renewal
process for stem cells.
Following, CD44+ (a marker for gastric stem cells) expressions were
significantly downregulated in dioxin-treated organoids compared to the control. Thus,
dioxin-activated AhR reduced number of CD44+ cells in the gastric organoids.
These findings indicated that the gastric organoid established in this study is a
useful model to study cell proliferation and differentiation and require future analysis
on this AhR to study its regulatory role on gastric stem cell control and differentiation
studies.
4.3.2 Role of AhR activation in vivo
Dioxin-dependent effects of AhR were first identified in skin and liver cancers
(Barouki et al., 2007; Ikuta et al., 2013). Thus, in this study, AhR activation was first
confirmed by detecting activated AhR expression in liver. According to AhR
functional pathway, activated AhR should be detected in the nucleus as it acts as a
transcription factor. Immunohistochemistry revealed more nuclear AhR expression in
the dioxin-treated liver, which confirmed the activation AhR in liver. Then stomach
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was also examined for AhR activation, which was confirmed by intense nuclear AhR
staining and increased CyP1A1 gene expression in the dioxin treated stomach.
Present study investigated the role of activated AhR on surface mucous cells,
neck cells and parietal cells. lectin histochemical analysis for surface mucous cells and
neck cells showed that dioxin mediated AhR activation reduced the intensity of the
stains. In addition, it also reduced the intensity of H,K-ATPase staining in the parietal
cells. Though the effects were not significant, data from mucous neck cells somehow
correlated with significant data from the organoid experiment. These findings
indicated that dioxin-activated AhR has a significant role in gastric stem cell regulation
and differentiation.
Following the present provided data, more future experiments can be
conducted using organoid models as these mimic in vivo conditions. These organoid
models are more suitable than animal models for experimental purposes as less animals
can be used or harmed specially when considered to be tested by injecting harmful
agents.
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Chapter 5: Conclusion

In this study, two types of gastric organoids were developed. For the first one,
mGS cells were used with hanging drop method and the second was from neonatal
stomach glands using matrigel. Organoids grow in size with time. Cell labeling showed
that both organoids maintain live cells at the periphery and dying cells at the center.
Cells of primary organoids differentiate to form mucus-secreting cells. Organoids were
used to test the role of AhR on gastric stem cells. AhR activation with dioxin enhanced
the capability of stem cells for self-renewal and reduced their differentiation towards
mucus-secreting neck cells (Figure 34). Reduction in mucus-secreting neck cells
correlated with results of dioxin injection into mice and with the upregulation of AhR
during gastric carcinogenesis.
This study provides novel findings regarding the generation of two new types
of gastric organoids and also new insights into involvement of AhR in stem cell
regulation which could provide some explanation for its role in gastric cancer
progression. These data will be useful not only for gastric cell biologists and molecular
biologists, but also for gastroenterologists and gastrointestinal surgeons making
decisions regarding diagnosis and staging of gastric cancer, the most fatal and second
most common cancer among gastrointestinal tumors.
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Figure 34: Illustration of overall findings on role of AhR on gastric organoids. Dioxinactivated AhR increased cell self-renewal and decreased cell differentiation in the
gastric organoids towards mucous neck cells.
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Chapter 6: Future Prospective
Organoids are novel representative models that mimic in vivo conditions and
can be used for studying stem cells either involved in organ development or in
pathogenesis of various diseases. Therefore, these models open up great possibilities
in the field of biomedical research for modelling diseases, regenerative medicine,
testing new therapeutic approaches and other biological studies.
In this study, the first organoid model from mGS cells will be a useful model
to study the cell renewal process, as the cells continuously proliferate in the organoid
with live and healthy cells organized at the periphery and dead cells accumulated at
the center. These models can also be used for long term research purposes as these
organoids can be maintained for many months.
Moreover, this study is the first to generate organoids from neonatal gastric
glands. It would be interesting to compare the characteristic features of these organoids
with ones from adult glands as the neonatal glands consist mostly of stem/progenitor
cells.
Most of the cells detected in the neonatal gland-derived organoids at day 4
were mucous cells. However, some possible strategies can be tested further to drive
the differentiation towards parietal cells which may include: 1) co-culturing the
organoids with immortal mesenchymal stem cells or freshly isolated bone-marrow
mesenchymal stem cells, 2) co-culturing with fibroblasts, 3) extracting parietals cells
from adult glands and seeding them with neonatal glands, these adult parietal cells
could be the source of factors that drive differentiation into parietal cells as previously
suggested and 4) adding BMP or GSK3β inhibitor CHIR99021 to induce H,K-ATPase
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gene expression. All the above-mentioned conditions could be directly or indirectly
involved in stem cell differentiation.
These gastric organoids can also be used to model overexpression or
knockdown of stem cell-specific genes to study effects on cell proliferation and
differentiation. They can also be used to model gastric cancer and study stem cell role
in cancer development, as previous evidences suggest their possible involvement in
carcinogenesis. Finally, these organoids will be useful to model microbial infections
(bacterial and viral) and testing potential drugs or compounds involved in their repair
capacity.
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